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urea fliNG EVENTS
February 12 , Monday
Alumni reception at the meeting of the American Academy of
Dermatology, Washington, DC
February 22, Thursday
Alumni Executive Committee meeting
February 23, Friday
Alumni reception at the meeting of the American Academy of
Orthopaedic Surgeons, Atlanta
MardI 15 , Friday
Parents' Day for sophomores, sponsored by the Alumni
Association
Apri l 8, Monday
Research symposium and ceremonies in honor of Robert L
Brent , M.D., Ph.D., the Distinguished Professor of Pediatrics
Apri l 25, Thursday
Alumni Annual Business Meeting
Apri l 26, Frida y
Alumni reception at the meeting of the American College of
Physic ians , San Francisco
Apri l 29, Monday
Alumni reception at the meeting of the American College of
Obstetricians and Gynecologists, Denver
May 7, Tuesday
Alumni reception at the meeting of the American Psychia tric
Association , New York
JUlie 15-26, Saturday-Wednesday
Trip to Alaska (see page II)
JUlie 16-19, Sunday-Wednesday
Conference on the Molecular Biology and Pathology of Matrix,
hosted by the Department of Biochemistry and Molecu lar
Biology (phone 215 955 2025)
Reunion W eekend '96
JUlie 7, Friday
Alumni Banquet
JUlie 8, Saturday
Clini c Presentations, Dean 's Luncheon, Reunion Parties
JUlie 9, Sunday
Farewell Brunch
Order Now: 12Sth Anniversary Video
The Rise of the Morning Star
See the video about Jefferson Medical College commission edby the Alumni Associa tion for its 125th anniversary.
The Rise oj the Morning Star has been described as
"Exce llent. Abso lutely exce llent. "
-Fredericll B. Wagner Jr. '41, The Grace Revere Osler
ProJessor Emeritus oj Surgery, and Univ ersity Historian;
A lull1 ni Preside nt 19 75
"It makes me pro ud all over again to be a Jefferson alumna."
- Nancy 5. Czarnecki '65, Alumni President 1989
The cos t of the video is $19.95 including mailing.
To obtain your copy, call the Alumni Office at 215-955-7750 ,
fax 215-923-99 16, or mail the form below with your check to:
1020 Locust Street, Suite M-4 1, Philadelphia , PA 19107 .
~ .
Namc Class Ycar or Jc ff Affiliation __
Mailin g Address _
City State Zip _
Daytim e Phone _
Enclose check for $ 19.95 (incl udes mailing)
payabl e to Jefferson Medica l College
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A centerpiece of the 125th anniversary
celebration of the Alumni Association was a
symposium on the theme "A Vision of 2020:
A Look at Medicine in the Future." Featured
speakers were Robert L. Conus. M. D ..
Clinical Director of the lefferson Cancer
Center: Richard A . Insel '69. the Goler
Professor of Pedi atr ics at the University of
Rochester. and Di rector of the Strong
Chil dren's Research Center: and D arwin I.
Prockop. M.D .. Ph.D .. Chairman of
Biochemist ry and Molecular Biology at leff.
Their talks are adapted in the fo llowing pages.
We Will Fight Cancer with
Molecular Therapeutics
and Prediagnostics
Robert L Comis, M.D.
Thinking for a mom ent about the last 25 years, a hand ful ofclues abo ut cancer biology have put us whe re we are today .
One was the study of retinobl astom a, which occurs in two forms,
heredit ary and nonhereditary. It was hypothesized that children
who have the hereditary form already carry an abnormal gene
and that once they develop the cance r, further alte rations occ ur.
A seco nd was the development of viral onco logy and the
realization that viruses cause human cance r; th e Philadelphia
chromosome discovered in the 1970s was the first cons istent
abno rmality show n in cancer. It was kn own throu gh out the 20th
century that che micals cause cancers . Ultima tely these few hint s
led to the definition of oncogenes that arise in the normal
genome an d are associated wit h viruses. Oncogenes are genes
wh ich up-regul ate cell division; if they are mutated or translo-
cated to another spot they often are unr egul ated and the cells
divide ou t of control. Tumor suppressor genes are ones which
dampe n the abi lity of cells to div ide ; if they mutate the cell is
un controlled. Recently ano the r seminal d iscovery has moved
research to a high er plan e: the discovery tha t we all have genes
which repair D A damage and that if these genes are mutated it
am plifies the errors that will lead to cancer, part icularly that
caused by che micals.
What know ledge base allowe d us to have these insights? Th e dis-
covery of DNA in the past qu art er -century, and then the ability
of biotechnology to evalua te DNA in real time in human disease.
A field whi ch is a harbinger of where we are heading is colon
cancer. We know tha t it occ urs from the pro gression of
adenomatous pol yps developing into carcinomas. Some
carcinomas are cured with surgery; others develop metastasis.
This was the classic defini tion in the I970s. We now kn ow that
mutation of the po lyposis gene is probably an early event. We
know that a variety of mutations and other gen etic alterations
occ ur which drive these cells towards the development of
invasive cance r.
So we have a redefiniti on of this disease . To see wh ere the field
is goi ng, let's run th rou gh the areas that we cancer clini cians
deal with. First, prediagnosis: before any detection of cance r,
finding out who is predisp osed to cance r. Twenty -five years ago
we had the family history; we kn ew certai n pat ients were in
cance r families, or that there was a tremend ous predisp ositi on
for cance r but that 's all we knew . We used the social histo ry and
cytology and we had a so rt of avo idance coun seling.
ow we kn ow that there are certain genes whi ch are inh erit ed
and cause certai n cancers to occur in families: the BRCA-I gene
in breast cancer, the APC gene that causes polyposis. The
transition has been tremendous; as op posed to mere avoidance
counseling there are trials going on aro und the worl d wh ere we
are tryi ng to actua lly pr even t can cer based up on the ability of
certai n che mica ls to modul ate the development of cance r.
Where will the field of prediagnosis go ? There's no qu estion in
my mind that in 2020 we will have available to us, as part of our
ro utine care, a gene tic profi le of risks . This will bring up all
so rts of ethical and soc ial qu est ion s that are going to have to be
addressed. But we will be able to know what the pa tients'
consa nguinity gene types are and wha t the risk is; if there is
counseli ng or int ervention it will be based up on these risk
patt erns. Also , inst ead of having tests like the stoo l guaia cs,
sputu m cytology , urine cyto logy, biochem ical bloodstreams
we'll be looking at spec ific geno types in these organs to
determ ine whe the r or not the cancer is in process or wheth er
the first mistake has been made and the second mistakes will
follow . We will move toward s biochemi cal, genetic, or
molecul ar tests.
ext, chemo prevention will become part of everyday practice.
Lastl y, I can' t believe people aren't going to want gene surgery if
it's possible. ot j ust for cancer, but for all disea ses. This is
going to have a tremendous impact on social , religious, and
ethical areas.
As for diag nosis: 25 years ago , histopatho logy was the key to
diagnosis. Gene tics was rudimentary; you could look at the
chromosomes but even the banding tech niques tha t we have
today were not available and we had non specific biochemical
tests. Histop ath ology today still is a critical part of diagnosis of
cance r but now we have molecular markers wh ich are based on
so me of the genes I mention ed . We kn ow the gene that is the
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Senior Vice President and Dean Joseph S. Gonnella. M.D.
(at left . with Dr. Comis) moderated the symposium.
most important prognosti c factor in neu robl astom a. Th ere are
other genes which can tip us off to the malignant pr ocess.
A major field is how translocations lead to cance r: one gene is
transposed to ano ther area and the disregulati on of that gene
causes cancer. Carlo Croce , M.D., Director of the Jefferson
Cancer Institu te, discovered that when the bcl-2 gene was
transferred from chro mosome 14 to 18, it was a critical event in
the development of lymphoma. Similar translocations cause
acute promyelocytic leukem ia and chro nic myelocytic leu kemia.
We now know biochemi cal markers that are highly spec ific for
cancer, HCG for testicular cancer, CA125 for ovarian cance r,
PSA for prostate cancer. The transformation of onco logy in 25
years has been substantial.
Some of the major adva nces of the future wil l relate to the fact
that we will have specific blood tests to evaluate whethe r or not
the malignant process has occurre d or is occurring in spec ific
organs. An examp le right now
is PSA but this is going to be
much more highl y specific;
we'll get a cancer "panel" for
different organs .
The other thing that' s goi ng to
revolutioni ze diagnosis is the
ability to diagnose cancer at a
very low tum or burden. Stage is
clearly related to leth ality in
cancer; the lower the stage , the
more likely the cure . In the
next quart er-century the whole
area of highly specific diagnosis
is going to evolve to a very
practical level. We started out
with monoclon al ant ibodies
whic h are highl y specific ways
to target certa in types of tissu es
based on the immune system.
Now we can molecul arly engi-
neer molecu les tha t instead of being 150,000 molecul ar weight
are 15,000 and that will go down to the point where we can tag
the molecul es that we are interested in to diagnose cance r early.
A paradigm for future development exists in thyroid cancer
wher e with radioimmunodiagnosis you can locate metastasis and
kill it. Eventually we'll be able to do this for breast , colon , lung,
and othe r major tumors. Diagnostic path ology will increasin gly
become molecul ar and there will be molecul ar definitions of
diseases I menti on ed .
As far as prognosis, we talk ed 25 years ago about stage and
grade , very cru de ways to evalua te prognosis. Now we have not
only a clinica l path ologic stage but a prognostic test based on the
molecular mark ers which I menti oned and the ability to detect
metastasis at a level which is vastly bett er than it was before. The
ability to prognosticate will be dramatically different in 2020 .
Classic histopath ologic diagnosis will be au tomated, I believe.
Wha t we really need to know is who are the peopl e at risk to die
from cance r and the molecular definit ion of that lethal potenti al
I th ink will be clea r by 2020 and we'll be able to intervene, in
the peopl e who need it , in a highl y specific way.
In the next qua rter-century we will be down to molecular defini-
tion of therapeut ic targets. Instead of going after breast cance r
we will go afte r a specific gen e. We'll start thinking about cancer
in a process-oriented way in onco logy, in fact all of medicine,
and the organiza tion of medical schoo ls will change as a result.
Let us conside r therapy. In 1970 we were driv en exclusively by
the use of chemo therapeutics. Their effects were not spec ific to
cancer. Bu t in spite of that it was clear in 1970 that drugs could
cure at least four cance rs including child hood acut e leukemia or
Hodgkin 's disease. Yet the abili ty to impa ct on the major cancers
really didn't exist. And
tran splant technology relative
to cancer was rudiment ary.
Twenty-five years later we can
cure about 15 cancers with
chemicals. We can defini tely
impac t on major diseases like
breast and colon cancer if we
treat them early eno ugh.
Auto logou s bon e marrow
transplantation is a routine
therapy at present. And ins tead
of having a tota lly empirical
approach to drug developm ent
we now are after specific gene
produc ts such as tum or
suppressor genes or signal
transduction factors. Right
now we are targeting these
areas as well in developing
drugs tha t are designed by
computer rather than discovered empirically.
Wh at's cancer therapy going to be in 2020? Th ere will still be
some role for cyto toxics but it will be meager. And on ce again
therapeu tics in cancer and other areas will be orient ed towards
processes ins tead of diseases , for example apo pto sis which is
imp ortant in normal immunology as well as cance r. We will
have specific drugs directed towards signal transductions, the
ability to repair or replace genes, and the abili ty to alter how
tumor cells grow relative to their environment. In all of
medicine pharmacologic agen ts will be highly specific, targetin g
th e heart if you have a heart probl em , the lun g if you have a
lung problem , the cancer if you have a cance r problem.
Lastly, it has been known for a cen tur y that the immune system
can be altered to fight and elimina te cancer , yet the ability to do
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Medicine, and the
organization of
,nedical schools,
will change. We will
look at cancer in a
process-oriented way.
Dr. Insel answers an audience member's Question.
(continued from preceding page)
this in real time and in a rea l way has not reached its potential.
The 21st century will be the daw n of effective immuno thera-
peutic agents. Right now it is clear that there are certain ways
to approach this and they'll play out in the next 25 years.
Four areas that the j efferson Cance r Center has staked out
will yield ore th rou gh the beginning of the 21st century.
1) Computer-bas ed dmg design: we are
seeking to develop compounds such as
one that inhibits certain imm une func -
tions , or modulates immune function ,
both in auto immune disease and in
tran splant. Th is is the first of a series
wh ich will come from our pro gram.
2) Molendar diagnostic alld therapeutic
research: including antisense
technologies , vectors, and
immunologic regulations.
3) Vaccinia virus vector: we're about to
start a trial looking at the vacc inia virus
vecto r and its ability to induce immune
responses to tumors. We have a pro gram
which is capable right now of repairing point mutations and
we're int o targeted therapeutics.
4) Apoptosis: this will remain a major focus of our pro gram.
Where are the quantum leaps going to be? Clearly the ones I
have describ ed will happen , but superimpose d on them will be
others whose imp act we canno t imagine.
Behavior
and Economics
Challenge Prevention
Richard A. lnsel '69
T wenty-five years ago my teachers at jefferson, like cur rentSenio r Vice President and Dean joseph S. Gonnella, M.D.,
taught me to cha llenge everything. It has held me in good stead
and it's going to be a vital trait for the next 25 years, because we
are going to see a lot of changes and we will need to make some
very tou gh decisions to adapt to these changes.
In this pr esentation , I want to tou ch on molecular medicine,
immunologic and infectious diseases, and potential impediments
that I see to any vision for the year 2020.
The Human Genome Proje ct began in the early 1990s and it is
estimated that within 18 months we will have 50 percent of the
100,000 genes in the human genome mapped , by 1998 we will
have 80 percent mapped, and by the year 2000 we will have all
th ree billion bases , encompassing 100,000 genes, mapped.
How is this going to change clini cal medi cine? We will see two
major effects . First , it will radically change our und erstanding of
medici ne and disease and how we approach medicine.
Wha t does this mean for clini cian s? Medicin e will now be
approached as both gene-based and pathophysiology-based . In
the past , we often did not fully understand the basis of disease.
This is going to change. We will definitely see new diag nostics
with population -based screen ing for
diabetes, cance r, schizophrenia , and
obesi ty (jefferson will lead the way with
the work of its Chairman of Medicine,
j ose Caro IM'78).
We will definit ely see new therapeutics
result from this gene-based background.
We will see small molecule therapy, gene
therapy, new delivery systems , and even
the ability to replace abn ormal genes by
hom ologous recom bin at ion (cutting out
the mut ant genes and putting new ones in).
All of this I hope will lead to what our
goal sho uld be in medicine: prevention.
But wit hout a doubt, prevention is going to be much harder
because for man y diseases, prevention requires a change in
behavi or. It will pro ve quite difficult to change human behavior.
evertheless, one of the first steps in preventi on will be to know
the exact cause of disease.
In immunology and infectious diseases, the past 25 years will be
a pro logue for the next 25. First, we'll see a reemergence of
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Many diseases
largely result from
behavior: To ignore
this would be
dire, in spite of
molecular medicine.
infectious diseases. Second, we'll see a new assoc iation of
microbes with disease. Third , we'll see vacc ines bein g used
widely for exci ting new applications . Four th, we'll see
immunology being applied to many different fields.
Infectious disease is truly a burden in medi cin e today. It
represents a leading cause of death and disability wo rldw ide . In
the United States, it acco unts for 25 percent of all physician
visits , with a cost greater than $ 120 billion an nually. Th ese
problems are not going to go away . It's been said , "ingenuity,
knowledge , and orga niza tion alter but cannot cancel human ity's
vulnerabi lity to invas ion by parasitic life forms. Infectious
disease which anteda ted the emergence of humankind will last
as long as human ity itself and will sure ly remain one of the
fund ament al param eters and determinates of human history."
We saw cho lera in South Ame rica in 1991 , diphtheria epidemics
in the Soviet Union in 1993, pn eumoni c plague in Indi a in
1994, ebola in Zaire th is year.
Epidemics are no t unique to the deve lop ing world. In the
Uni ted States we have serious problems
with an tibio tic-resistant bacte rial
infections and AIDS. Last year,
"Cryptosponduun" acco unted for an
outbreak of 400 ,000 cases of diarrhea in
Milwau kee because of a contaminated
water sup ply. Infectious disease is going
to continue.
I wou ld never have believed 25 years ago
tha t we would see so many new diseases
associa ted with microbes. Rotavirus
wasn't desc ribed until 1973; we now
know it's the most common cause of
infantile diarrhea. In rece nt years we've
enco unte red Legionnair es' disease, Lyme
disease, and AIDS. And if I had told my professor at Jefferson ,
o. Dhodanand Kowlessar, M.D., in 1969 that we wo uld be
trea ting pep tic ulcer disease with antibiotics to trea t a bacterial
infection (Heticobacter pylori) rat her than lowering gastric
acidit y, I would have been called craz y.
Looking toward the year 2020, I am sure we will discover a vira l
etio logy for diabe tes. There may be an infec tious contribution to
coronary artery disease and restenosis with a contribution from
Chlamydia pl1cllmol1iac and cytomega lovirus . The re is evide nce
that viruses may be cont ributing to the hypert ensive renal
disease in black urban populations. We are going to see man y
viruses associa ted with cancer. Papill omavirus is associated with
cervica l cancer and I thi nk that we will see viruses associated
with lung, bladder, and esophageal cancer. Hcucobacter pylori is
not on ly associated with gastric ulcers but also gastric
cancer-here is a cancer tha t can be prevented or treated with
antibiotics! We will see, I th ink, infec tious etio logies ident ified
for arthr itis, multiple sclerosis, inflammatory bowel disease,
Alzheimer's disease, and sys temic lupus ery thematosus. So two
of the themes of the future will be new, emerging, or
reemerging diseases, and new asso ciation s of microbes with
disease.
Th e th ird them e will be new vaccines. Th ey are the most cost-
effective form of prevention we have. I was involved in
developing a vaccine that prevents Hacmophillls il1jlllcl1 zac b
disease, which used to be the most common cause of meningi tis
and bloodstream infections in children. This vaccin e was
introduced in one form in the 1980s and a more sophisticate d,
seco nd-generation form in the 1990s. Th e vaccin e has decreased
the incidence of this disease by 95 percent. Th e cos t from the
federal sec tor to develop th is vaccine was approximately $20
milli on . The Office of Management and Budget calculates that
this vaccine is savi ng the Ll.S, approximately $450 million
annually.
Vaccines will be a recurring theme during the next 25 years .
First, we have new vaccine technologies. We have recombinant
vaccines, novel viral vectors, and pep tide
vaccines. It's even possibl e now to use
naked 0 A to immunize animals agains t
influenza, rabies, and herpes virus. We
will see the use of DNA vaccin es in
hum ans. DNA vaccin es represent a very
significant breakthrough in vaccine
development. Th ey provide a simple
approach to developing vaccines and
these vaccin es will be heat-stable, an
important advantage in the develop ing
world.
We are goin g to have new delivery
systems. Besides immunizing
parent erally as we do today, we will see
the adven t of ora l vaccines against diarrheal diseases, sex ually
transmitted diseases , and respirato ry diseases. We cur rently
have the ability to generate vaccin es in plants and it is
conceivable that we will be using our vegetables to deliver
vaccines in another 25 years. It could pro ve a very cos t-effective
way of vaccinating in the developing world. Finally, genetic
immunization will develop that allows introduction of genes
into the hum an genome.
Where do I see these vacci nes being used ? I believe we'll have a
vaccine that will prevent HIV and also a therapeutic vaccine for
HIV wit hin the next 25 years. We will see new vaccines for
malaria. We will have vacc ines mor e effective than BCG (Bacille
Calmette-Guerin) for tub erculo sis. We will have vaccines for
gonorrhea, leprosy, and the two big killers in the develop ing
world-diarrheal diseases and resp iratory diseases.
It's the goal of the Children's Vaccin e Initiative, whi ch was
started by the World Health Organization in 1990 , to develo p
for in fan ts a vaccine that combines all chi ldhood vaccines in one
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As for AIDS, even if a vaccine is developed , I
am not sure that we can handle the existing
world wide burden and its eco nomic ramifica-
tions. Today, there are approximately 12 to 16
million people in the world who are infected
with HIV, of which one million are in this
country. By the end of this decade , that
number will reach 30 to 40 mill ion, of which
10 million will have developed AIDS.
It is ideal to eradicate disease, yet we've had very few successes.
The one tru e victory was smallpox, which was declared
eradicated by the World Health Organization in 1980. We
eliminated poliomyelitis from the Americas by 1991. Our target
is to eliminate polio from the world by the year 2000 . The next
two goa ls will be to elimina te measles by the year 2010 and
possibly neonatal tetanus and leprosy by 2020. But this is a very
sho rt list. There are not man y diseases that we'll be able to erase
from the globe.
And befor e we becom e complacent, conside r some leading
causes of death in our own country: heart disease, cancer,
stroke, chronic obstructive lun g disease, accide nts, suicide, and
hom icide. Many of these diseases are roo ted in behavior or low
economic status. To ignore that wou ld be dire. I fear that many
of these leadin g causes of death today will still be on the list in
the year 2020. Some of today's problems should have been ad-
dressed 25 years ago, in 1970. I fear that 25 years from now, in
the year 2020 , we may be trying to figure out why we neglec ted
to solve some of these preventable diseases back in 1995.
Are toda y's advances going to alleviate the major causes of death
worldwide-ischemic heart disease, cerebral vascular disease,
chronic obstructive pulmonary disease- or are we going to have
to come up with new strategies? For acute resp iratory infections,
diarrheal disease, malaria, measles, tub erculosis, neonatal
tetanus, we do have good vaccines for some of these infections,
and we will see imp roved vaccines . But the question will remain ,
can we deliver these vaccines to the developing
world in a cos t-effective fashion? The Ll.S.
does not have a great track record in this
regard ; our own immunization rates are
dismal.
We have a problem in the publi c percept ion of biomedical
research and science . Both physicians and biomedical
researchers must becom e real advocates for research and science .
The way the public perceives us will be central 10 wha t will
happen with health care reform .
We are going to face tough ethical decisions about the distri-
buti on and delivery of care. Advances in genetics will generate
new ethica l dilemm as. Also the qu est ion of us (or U.s .) versus
them: sha ll we conce ntrate on national health problems, or the
global picture? Poverty, famine, and war will impact on disease
and on our decisions.
Are we
training M.D.s
who can
understan
he science if
the year 20207
But, I see some very dark clouds on the
hor izon . We face three major impedim ents.
The first is tremendous eco nomic challenges .
With any sort of health care reform and
managed care, the financing of biomedical
resea rch is going to be a real question mark.
There is a move afoot to cut back federal
funding for biom edical research . The biophar-
maceuti cal indust ry does not have the research and
developm ent dollars to invest that they have had in the past.
Second, we face work force challenges . We must ask ourselves ,
are we training M.D.s who can understand the science of the
year 2020?
Third, we will have major soc iologic cha llenges to any kind of
vision for the year 2020. Many of the diseases that we are faced
with are societal diseases, for example, the association of lung
cancer with smoking. It has been 30 years since the Surgeon
General warned of the dangers of smoking. AIDS exemplifies
how behavior must be changed to have an impact on disease.
In spite of molecular medicin e, beha vioral aspec ts of medicine
cannot be ignored.
There is no qu estion that much disease that we see toda y is du e
to lack of access to health care. I am not sure how well we will
address this problem in the next 25 years. The questions are
tough. Wh at cos ts are we willin g to pay for improved health?
Do we put our mon ey int o prevention or into therapy?
I think we'll understand the aging process, but we will onl y see
the lifespan increase by three to four years in the next quarter-
century . There will be inh erent limitations to preventing aging.
We will come to understand the pathogenesis of ath eroscle-
rosis, though whether we'll change behavi or to prevent
atheroscleros is is qu est ionable. I think we will have real cures
for asthma. One of the grea t areas of
advancement will be in the neurosciences. I
think we'll be able to regenerat e neural tissue
and understand the organic basis of mental
illness and make great advances in brain
imaging.
(continued from preceding page)
dose, administered near birth, which is heat-stable, affordable ,
and which pro vides lasting immunity. I think we will reach
this goal by the year 2020 .
Immunology is going to provide us with two tools that will be
extremely useful. We will be able to activate or turn off the
immune system at will. This will be appli ed to allergic diseases
and asthma, auto immune disord ers, multiple sclerosis,
diabetes, lupus, rheumatoid arthritis. and cancer. There will be
cance r immunotherapeutics, tumor-specific vaccines, and even
the ability to replace tumor suppressor genes as Dr. Comis has
discussed (in the preceding article).
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With Genetic Understanding
of a Disease We Can
Prediagnose-and Cure
Darwin]. Prochop, M.D., Ph.D.
A litt le boy was born about 20 years ago and he appearednormal at birth. His pedi atrician carefully examined him
and found a littl e un expected curvature of the back , but
nothing else of significance. At the age of one month, his
mother brought him to th e emergency room with a broken leg.
Th e initial diagnosis was battered child syndrome. By the time
the child was 21 months of age , however, he had broken all his
limbs repeatedly and had several fractures of his ribs. On
several occasions, he broke a limb simply by rolling over in
bed. Each fracture hurt as mu ch as it would hurt you or me,
and the bones see med to rep air at a normal rate , but the
repaired bone was always weak.
The child in fact had osteoge nes is imperfecta or brittle bone
disease. The condition intrigued us for a number of reasons.
Init ially, we were interested in defining the reason for the
bone's weakness . We spent several years tryin g to analyze the
type I collagen, the most abundant protein in bon e and a major
source of its strength . We then turned to analyzing the D A
that contains the genes for collagen. D A is heaven 's gift to the
experimental biologist. It is extremely easy to isolate and to
analyze. You can obtain adequate amounts of DNA for most
experime nts with five ml of blood or even 10 ml of saliva. Th e
quality of the DNA in saliva is not as good as that obtained
from blood , but it is sufficient for many experiments.
The pro cedures for isolating the DNA are remarkably simple.
You place the sample of blood or saliva in a tube, add a
protease that will destroy all proteins, add a detergent that will
disrupt cell membranes, and allow the sample to sit overnight.
The next morning, you add organi c so lvent ; shake the tub e,
pour off the organic so lvent to get rid of the debri s, and add
salt and ethano l. You coo l the tub e and come back in an hour
or so. Examining the tub e, you see a wh ite cloudy mat erial. If
you pass a pipett e th rough the cloudy mat erial and pull it out,
you will have extrac ted strands of pure D A. Th ese simple
steps provide D A that is highl y pure and stable for long
periods of tim e with minimal precautions.
In the case of the boy with brittle bon es, we extracted cellular
D A and analyzed the struc ture of the genes for type I
collagen. DNA is a simple molecul e in that it consists entirely
of long strings of subunits called bases that are the four
different lett ers of the gene tic code. Th e DNA in human cells is
contained in 23 pairs of chromosomes , and each chromosome
contains a strand of DNA that comprises about 50 million
bases. If the D A in all the chro moso mes were linked together
and stretched ou t, it woul d form a strand about five feet long ,
conta ining about three bill ion bases. If you look in detail at the
DI A, you find there are two kinds of regions, one that contains
bases that code for prot ein s and cons titute genes, and a second
that contains nonessential D A. The nonessent ial D A
accounts for 90 percent of the bases and does not serve any
useful function we know of except to serve as a filler or carrier
for the genes .
In the case of the boy with brittl e bones, we had prior
information that suggested that we sho uld look at the two
gen es that code for the two different kinds of polypept ide
chains found in type I collagen . To do this, we first isolated
regions of the boy's DNA that contain ed the collagen genes and
then anal yzed the collagen genes by DNA seque ncing.
Sequ encing is carried out by a standard recipe that involves a
large number of manipulations, but is relatively simple. The
final step is to take the sample of DNA that has been treated in
four separate ways, place it in four di fferent lanes of an
electro pho retic gel, and separa te the D A by electrical current
that passes throu gh the gel to generate an array of bands. The
display of bands in the gel is read eit her from the top of the gel
to the bottom or from the bo tto m to the top. The base sequence
of the D A is defined by whe ther a band appears in a lane
labeled as A, G, T, or C.
In the D A seque nce from the littl e boy, every band on the gel
was the same as in the cont ro l exce pt for a thick band of two
Cs. At this positi on , the boy had one C and one band
indi cating an A. In effect, he had a mutation that convert ed one
of the bases kn own as C to a base known as A. As a result, this
region of one of his collagen genes coded for the amino acid
cysteine instead of the amino acid glycine. The presence of
cysteine instead of glycin e at this position in type I collagen
mad e it a defective pr otein . In effect , a mutati on tha t converted
one of his thre e billion bases to ano ther base was the cause of
his brittle bones.
T here are several practical consequences of being able tocarry ou t this kind of diagnosis in children with osteoge-
nesis imp erfecta . On e is that the results will provide definitive
evidence that the child in fact does have a genetic disea se and is
not a batt ered child. Sadly, a number of families with children
having osteogenesis irnperfecta have been accused of the
battered child syndro me and legally prosecuted . A definitive
D A diagnosis as descr ibed above can prevent th is tragic event.
Ano ther pra ctical consequence is that famili es that have one
child with seve re osteoge nes is irn pe rfecta have an eight percent
cha nce of having a seco nd child with the same disease. If the
famil y desir es another child , amnio tic cells can be obtained at
about 16 weeks of a pregnancy or cho rionic villi cells can be
obtained at about eight weeks. The cells from these two sources
can be analyzed for the presence of a mutat ion in the collagen
gen e, and a diagnosis can be made as to wh eth er the new child
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has the disease . Thus genetic information can be used to reach a
decision about a therap eutic abortion.
In the course of studying the child with osteogenesis imp erfecta,
we carried out on e criti cal experime nt to prove tha t the
mutation was in fact causing his bri tt le bones . We took a
mutated collagen gene similar to the one found in the boy and
used it to prepare tran sgeni c mice . The steps here , again , are
relatively simple. D A containing the mutated gene is injected
int o a one-cell mouse embryo which is then implanted into a
pseud opregnant mouse. After the inje ction into the embry o, the
mutated gene is, by seemingly magical s teps, incorporated into a
chromosome of the embryo and expressed as a prot ein.
Therefore , this pro cedure allows you to prepare transgenic mice
that conta in a mutated human collagen gene as part of their
own chro moso mes, and to express the mutated gene as faulty
collagen. Th e net result is to produce mice that have brittle
bones similar to the brittle bones seen in the children. Th e
experiment is a dir ect way of dem onst rati ng tha t the mutated
collagen gene can in fact cause brittl e bones .
The transgeni c mice express ing the mu tated collagen gene, inturn , allowed us to take the wo rk one step further and
address a critical qu estion : was there any way that we could
help children with this disease?
Until three years ago, I was convince d that br ittle bone disease
was one of the worst possible diseases in which to try any type
of gene therapy. Th e problem is simply that all the bones are
involved in the disease and, therefore, any therapy would have
to repair all the bones. Other human diseases seemed like mu ch
easier targets for gene therapy. Recentl y, however , we have
succeeded with an experiment tha t makes us extremely
optimis tic that it will be possible to devise a thera py for britt le
bone disease.
The study, carried out by Ruth Pereira , Ph.D. in my laboratory,
and by Michael O'Hara, Ph.D. in Professor Dennis Leeper's
laboratory at Jefferson , was initiall y designed as a marker gene
experiment in whi ch a marker gene was used to follow the fate
of cells that were infused sys temically into mice. The cells we
were interested in are called stromal cells from bone marrow.
Marrow stromal cells have seve ral unique properties. One is tha t
they are easy to isolate. If you place bon e marrow in a cul ture
dish , most of the cells float , but about one in 1,000 cells sticks
very tightl y to the plastic of the dish . Th e cells that s tick to the
plastic are qui escent for three or four days, but then begin to
divide rapidly. These cells have been studied extensively for
over 20 years and have been shown to be precursors of bon e.
They will form colonies of bone if culture d under certain
conditions . They will also form bone if placed in a capsul e and
inse rted under the skin of an animal.
In our experime nts, we asked the questi on : what happens to
mar row stro mal cells if they are infused systemically in to an
animal? Specifically, we wan ted to kn ow whether cells infused
systemically will home to bon e and replace some of the cells
initially found in the bon e of a recipient animal. There were
several indications that an expe riment we designed migh t work,
but no one had actu ally perform ed the experiment. The key to it
was that by taking marrow stromal cells from a mouse
expressing a mutated collagen gene, we had cells containing a
marker gene with whi ch we could follow the fate of the cells in
great detail. One week after we infused the cells into a normal
mouse, we could not find any of the donor cells in any of the
animal's tissu es. After one month or five months, however, we
found that the donor cells replaced th ree to 10 percent of the
cells in a number of tissues in the mouse. It was no surprise that
the do nor cells were found in mar row and spleen of the
recipient mouse becau se these cells are closely related to bon e
marr ow. Th e pleasant surprise was that the donor cells had
repla ced the bon e cells in the recipien t mouse to about the same
extent that they had replaced the marrow cells. Therefore, the
injected cells had in fact acted as precursors of normal bone .
The experiments have several impli cati ons. One is that they
raised the possibility that normal marr ow stro mal cells can be
used to treat a child with osteoge nesis imp erfecta. The norm al
marrow stro mal cells will have to come from a donor who is
immunologically matched to the child with osteogenesis
imp erfecta. Also, the child with os teoge nes is imperfecta would
probably have to receive chemo therapy to "create a space within
the marrow" for the donor cells. Th erefore, the therapy has
some potential risks to the child. At the same time, some
children with osteoge nes is imp erfecta have severe variant s of the
disease that pr oduce death within a few weeks or months after
birth. In suc h children , the risk of treatment wit h normal
marrow stromal cells is prob ably warranted . In fact, a clinical
trial of this therapy will probably begin within a few months at
one of the leadi ng centers for bone marrow tran splants in the
Unit ed States.
T he seco nd implication of these experiments is that it may bepossibl e to isolat e marrow stro mal cells from a child with
brittle bone disease, correc t the gene defect by cult uring the cells
under appropriate conditions in the laboratory, an d then return
the corrected cells to the child . A number of technical problems
must still be overcom e in carrying out this strategy of correcting
the gene defect in marrow stro mal cells from a child , but we are
optimis tic that the obstacles can be overcome. These are the
experime nts that my laboratory is now engaged in.
In the future, wh at we have been learning about the relati vely
rare disease of osteogenesis imp erfecta may have applications to
more common diseases. We are hopeful that in the future ,
strategies similar to those that we and others are trying to
develop in the therapy of osteoge nesis imperfec ta may be
applicable to more commo n diseases of bone such as
osteoporosis and perhaps to common diseases of cartilage such
as severe generali zed osteoarthritis. IQ
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Jefferson Medical College Alumni Association invites you to join a
VOYAGE OF THE GLACIERS AND
TOUROF DENALI NATIONAL PAR
JU~ 15-26. 1996
An educational getaway: enjoy the beauty of Alaska with fellow Jeffersonians
Hosted by William V. Harrer '62, Past Alumni President and Professor of Pathology
General medical update topics will be presented by faculty and alumni
Led by Jerome J. Vernick '62, Clinical Professor and Director of the Trauma D ivision
7/15 Sailfrom Vancouver Your
ship the Sky Princess awai ts you
at the pier in Vancouver , B.C.
We'll welcome you aboard and
escort you to your cabin . We'll set
sail for the stunningly beautiful
Inside Passage early this evening.
7/16 Inside Passage (Cm is ing)
Enjoy your first day of Princess
pamp ering as your ship cruises
this scenic waterway.
7/17 Kete/likan (Port of Call)
They call this town the Salmon
Capital of the World, bu t it's also
known for its magnificent totem
poles. May we suggest an optional
tour to Saxman Village to watch
native carvers at work?
7/18 Jun eau (Port of Call ) Toda y
we'll call at Juneau , Alaska 's
capital, where an optional tour to
Mend enhall Glacier is a pop ular
shore excursion.
7/ 19 Skagway (Port of Call) Call
at Skagway- known as the
jumping-off point for the 1898
gold rush . Take in the Klondike
atmosphere on a variety of
exciting optional tours.
7f20 Glacier Bay or Hubbard
Glaci er (Cm ising) Toda y you'll
either cruis e through Glacier Bay
Nationa l Park or sail to Yakutat
Bay and past Hubbard Glacier for
a look at the massive rivers of ice
for which Alaskan cruising is
known .
7f21 College Fjord (Cn tis ing)
Enjoy an unforgettable day of
cru ising across Prince William
Sound and into College Fjord ,
famou s for its 16 gleaming
glaciers cascading to the sea.
7f22 Arrive Seward/Ane/wrage,
Fly to Fairbanlls This morning
we'll transfer you from your
Princess ship to the Anchorage
airport for your night to
Fairbanks. When you arrive ,
we'll take you on a delightful
riverboat cruise along the
Chena and Tanana rivers. Later ,
we'll transfer you to your hotel
for the night.
7f23 Fairbanks/Denali Today,
board our own Midnight Sun
Express Ultra Dome rail cars
and travel in style and luxury to
Denali Natio nal Park. Upon
arrival , we'll take you on a tour
into the park. Tonight enjo y ou r
comfortable Denali Princ ess
Lodge.
7f24 Denali/Anchorage Spend
some time exploring the park
on your own this morning or
enjoy an optional tour. Early
this afternoon we'll transfer you
to the Midnight Sun Express
and continue the scenic journey
to Anchorage, tonight's
destination.
7f25 Ane/wrage Spend the
morn ing discove ring Alaska's
largest, most cosmopoli tan city,
and its beautiful sur roundi ngs
on a tour. This afternoo n you'll
have plenty of time to enjoy
optional sightseeing tours ,
shopping, or exploring on your
own . Overnight again in
Anchorage.
7f26 Ane/wrage/Seattle We'll
transfer you to the airport for
the night to Seatt le and your
connections home .
Rates Include enti re trip package (c ru ise ab oard the Sky Prin -
cess with ex terior cabi n , plus land travel and lodging) but not air
transp ortati on to Vancouver or back home. Discounted rat es are:
Category Deck Rate
AA Lido $4359 .00 per person
B Lido 3689 .00
C Aloha 2829 .00
DD Baja 2739.00
D Baja 2649.00
EE Caribe 2559.00
E Caribe 2469 .00
Plus port tax: $206.00 per pe rson
Airfare fro m Philad elphia: $539.00 per person. Air fare from
other ci ties will vary. Please specify yo ur choice of departure city.
Or, yo u may mak e yo ur own n ight arrangements .
To assure your cabin choice ill tile ship, please ca ll Kelly Bradley
(see be low) as soon as possible.
I) Reserve Now for the Trip
COlltact: Kelly Bradley, Travel Counselor
American Exp ress Travel Relat ed Services
14 Sou th Haddon Avenue , Ha ddonfield , NJ 08033
Ph one 1-800-543-9 168 or 609-428-0810 Fax 609-428-7510
2) Register Now for CME Credit
To register, mail the form be low to:JMC Offic e of CME, Alum ni
Trip , 1025 Waln u t Street G-3 , Ph iladelphia , PA 1910 7. Enclose
your registratioll fee of $250.00 payable toJMC Office of CME.
Fo r questions regarding Co ntinuing Medical Educatio n credi ts ,
call th eJMC Office of CME at 215 955 6992.
~ ..
Name Class Year orJeff Affiliation _ _
Guest Name _
Preferred Add ress _
City Slate Zip _
Daytime Phone _
Yes. I am willing to give a one-hour educational presentation.
Thomas IJefferson
Jefferson Medical
University College
HOW W ILL COMPUTERS CHANGE MEDICA
Computer-Based Teaching Reshapes How Students Learn
John]. Gartland 5'44
T he practice of medicine is changing rapidly and medicaledu cation must adjust to these changes to keep pace. An
increasing body of research and medical knowledge and the rapid
development and deployment of technology in health care has
made computer managed information storage and retrieval an
absolute requirement for both clinical practice and medical
education. For example, the MEDLI E database of the National
Library of Medicine currently contains over eight million
citations and is growing at the rate of 35 ,000 citations per month,
a growth rate far beyond the capability of any physician or
medical student to keep pace with relevant medical literature.
Jefferson has responded to the need for information management
by creating AIsR (Academic Information Services and Research)
to provide leadership and service in managing scholarly
information, to create TJU information resources, and to improve
communication between students and faculty.
On a practical level this has merged Scott Memorial Library, the
Office of Academic Computing, and Medical Media Services into
a unified organization with specialized
functions relating to knowledge
management and communication. AIsR
has created J EFFLINE, a computer
program which links the Jefferson
community together and to distant
learning centers through access to the
Internet. A major local use for
JEFFLINE is to access the core health ~
sciences databases including MEDLINE. j
~CD-ROM for other databases concerned ~
with health care , such as BIOETHICs- ~
LINE, AIDsLINE, and Science Citation
Index are available on selected computers in Scott Memorial
Library. Plans call for eventually linking all Jefferson teaching
affiliates together throughJEFFLI E. A major educational initia-
tive of AIsR already in place is the support of an extensive library
of computer-based learning software programs and the promo-
tion of computer-based learning among faculty and students.
Headquarters for the computer-based learning initiative at
Jefferson is the Office of Academic Computing (OAC), located on
the ground floor of Scott Memorial Library. The OAC is headed
by Rodn ey B. Murray, Ph .D.,who, in addition to being Director,
Office of Academic Computing and Instructional Technology, is
an Assistant Professor of Pharmacology. The Office of Academic
Computing promotes state of the art computer-based training for
health care education. The OAC manages three open access
computer laboratories, supports a growing library of software
serving both educational and research needs and offers seminars
and workshops to faculty and students in support of accessing
information resources. For facult y members who are not
computer literate and who wish to become so , OAC will teach
them the requisite skills on request.
Proponents of computer-based learning believe usin g computer
learning programs can add to a studen t's knowledge base, can
stimulate student discussion , can reduce class roo m teaching
time and can be a convenience for both facult y and students.
The computer-based learning software library maintain ed by
OAC is extensive and covers both basic science and clini cal
topics. It has been acquired through software purchases and
through contributions from Jefferson facult y memb ers who have
created their own programs. At present the library contains,
among a vast array of other programs, 19 on anatom y, 15 on
biochemistry, eight on histology programs, six on microbiology,
seven on pathology, 15 on pharmacology, and seve n on
physiology. Instruction for the first two years of medical schoo l
now includes 51 computer-based learning programs, of which
nine are required by course directors and 28 are strongly
recommended to the student by course directors. A program
written by the National Board of Medical Examiners is a patient
simulation interactive videodisc program. Of the 51 computer-
based learning programs used during the first two years of
medical school at Jefferson, 34 programs were written by
Jefferson facult y memb ers.
Medical students can use these
programs in either of two compu ter
laboratories. One laboratory with 32
computers is on the third floor of the
Scott Memorial Library. The other
laboratory with 16 computers is on the
third floor of Jefferson Alumni Hall.
These laboratories contain only
Macintosh computers becaus e they are
believed to be easier to use for these
types of programs and also because
students prefer them. Most of the
monitors are 16 inches rather than the more usual 13 inches so
as to provide a bigger viewing area for these instructional
programs. A selected few come with even larger term inals.
These laboratories are open for student use from 9 A.M. to
10 P.M. , Monday through Friday, and for at least six hours on
Saturday and Sunday.
In addition, Jefferson belongs to the National Educational
Medical School Consortium (NEMsC), a consortium of 15
medical schools formed to encourage the collaborative and
cooperative development, refinement, assessm ent , and sharing
of computer-based educational materials using a common
hardware platform and common authoring systems. Beside
Jefferson, other member schools are Cornell , Dartmouth,
Georgetown, Harvard, Johns Hopkins, Mt. Sinai , Michigan , ew
York University, Penn, Rochester, Stanford, Syracuse,
Vanderbilt, and Yale. Jefferson students can download
consortium programs on to computer laboratory machines or
download them on a disk and run them on their own
computers. Some programs are examples of so-called
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Faculty members are findin g it increasingly helpful to use
computer-based presentations for lectu res and other teaching
purposes. An OAC Educational Technology Survey of selected
faculty in 1992 found that the majority of faculty respondents at
that time preferr ed to support their lectures with a 35mm slide
proj ecto r. Since then , however , the pendul um has swung .
sharply toward compute r-based presentat ions. Computer skills
training provided to faculty memb ers by OAC has been very
assistive in fostering this change in faculty attitude toward
lecture support methods. Course handouts can be computer
designed and printed for distribution to stude nts. Computers
visuals in
ADAM
with CT or
MR images.
With the
help of
student
interns, Dr.
Schmidt has
add ed text
information
for most areas of the bod y.
Dr. Schmid t points out that
student use of computer-based
learning can be expected to
increase rapidly once material
specific to ADAM and othe r computer-based learning programs
begins to appear on the examina tions .
ADAM has been touted to be the computer graphics program
that may replace hands-on cadaver dissection in medical schoo ls
some day. Dr. Schmidt does not believe that will occur in the
foreseeable fu ture because learning ana tomy is still a hands-on
experience. He believes it will be several decades before
computers can simulate the experience of a gross anatomy
laboratory but he does expec t these computer programs to
become more realistic as time passes. The National Library of
Medicine in December 1994 released on the Int ern et a three-
dimensional computer-genera ted "cadaver" known as "The
Visible Man. " This "cadave r" was crea ted from thousands of
images of a human body collected with state-of-the-art
radio graphic and photographic techniques. The composition of
the "cadaver" is so complex that those who wish to download it
in its entirety will need up to two weeks of un interrupted
Int ernet time and 15 gigabytes of computer storage space. The
National Libra ry of Medicine expects to release "The Visible
Woman" sometim e in 1995. The computer techno logy that
might make hands-on cadaver dissection obsolete som e time in
the future is virtual reality. For the present , however, virtual
reality is not practical for regular use in medical education or to
replace hands-on cadaver dissection in medical school anatomy
laboratories.
hypermedia,
a merger
of text ,
graphics,
video, and
sound in an
environment
which allows
the user to
manage and ~
process it. Richard The annual symposium on Computers in Health Care Education,
R. Schmidt, Ph.D., Associate sponsored by Jeff in conjunction with the Health Sciences Libraries
Professor of Anatomy and Consortium. includes dozens of presentations on using technology
Developmental Biology, typifies to deliver innovative instructional pr?grams. It ~s the only computer
the Jefferson faculty memb er conference designed for and by medical and allied health educators.
who makes good use of AISR
computer services, parti cularly electronic mail and computer-
based learning. Using e-mail for communicating with students
and the ADAM (Animated Dissection of Anatomy for Medicine)
software program establish ed as a course learning tool , members
of Dr. Schmidt's anatomy class have become "computerized"
more thoroughly than any group ofJefferson students to dat e.
Starting with the entering medical studen t class of 1997 , AISR
gave all first -year course coo rdina tors e-mail accounts for their
classes. Dr. Schmidt uses e-mail for course administrative details
such as dates and locations for examinations and laboratories
and other relevant class information. He has also int egrated
e-mail with the course material so that ins tructive questions
arising in class can be shared with all the stude nts, but he is
qu ick to point out that he does not supply e-mail answers to
these questions. He believes this type of activity is a good
learning experience for the students and points out that
students can find the answers to most of the questions in their
course material. Even after students have completed his course ,
Dr. Schmidt continues to send them anatomy and emb ryology
question s because he recognizes that students must keep their
knowledge of these subjec ts fresh for the first part of the
National Board Examination at the end of the second year.
Students are able to access e-mail through their home
computers, at Scott Memorial Library, and at other locations.
ADAM (Animated Dissection of Anatomy for Medicine) is a
commercially produced , self-pace d, self-directed computer
learning program and represents a much more complex
application of computer technology than e-mail. It run s off both
a CD and a network server, and has been called the "Gray's
Anatomy of the 21st Century" by facult y at medical schools who
have used it. Wh en viewed in the computer laborato ry of the
Office of Acade mic Computing, ADAM is trul y an exciting
educational experience and a convincing indi cator of how the
future of medical education will evolve. ADAM is a multimedia
program with beautiful pictures and excellent dissection
overlays. Faculty users can add text and pictures, make subrou-
tines, drop in Quick Tim e video segments, and cus tomize the
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can proj ect lecture outline material and all illus tra tion s,
including those with an audio component. Faculty members
wh o use computer-based presentations no longer need
carousels, 35mm slides or projectors. However, a screen is still
need ed wh en presenting information to large audiences. Using
a computer to project images to an audience provides more
advantages than using 35mm slides because it is cheaper in the
long run and last minute changes can be made in the material
to be proj ected , whi ch is impossible to do with 35mm slides.
computer-based presentations also allow the showing of
simulation programs to reinforce text information presented to
students. For example, when lecturing to students about drug
actions in pharmacology, Dr . Murray uses MACKINETlCS,
a simulation program designed to show students the
pharmacokinetics of drug actions.
While it is not quite accurate to say that, initially, faculty
members and students had to be dragged kicking and
screaming to the computer learning laboratories , it is tru e that
medi cal student acceptance and use of computer-based learning
programs at jefferson began slowly and followed a typical
learning curve. Over a relatively short time period, however,
faculty members have come to appreciate the value of
compu ters as teaching aids. In like manner, Jefferson medical
students have mad e increasing use of computer-based learning
programs as more and more students have begun to appreciate
the contribution computer-based learning can make to their
medical education. The computer labo ra tories now service a
swelling population of medical students.
At the present tim e the medical students use a program called
Versa Term to access their AISR e-mail accounts, theJEFFLI E
system, and the OVID search engine, which is Scott Library's
front end to the core data bases such as MEDLlNE, CINAHL,
and Current Contents. They use a program called NETSCAPE
to access JEFFLIN E's graphical in terface to the INTERNET on
the World Wide Web. DuringJanuary 1995 , a combined
Genetics/Informatics course was delivered entirely on -line to
the first-year medical students. The program combined
hyp ert ext , graphical images, and easy connections to major
knowledge bases su ch as MEDLINE and MICROMEDEX.
During the past quarter of the medical schoo l year , so ftware use
statistics generated in the computer laboratories indicate that
medi cal students spe nd about one-third of their computer
laboratory time on computer-based learning programs, one-
third of their tim e with ETSCAPE which provides acces s to
the INTERNET on the World Wide Web and one-third of their
time with word processing programs and spread sheet applica-
tions for data analysis. Freeing students of the constraints
imposed by fixed teaching times and classroom attendance,
computer-based learning programs can be expected to become
an even greater force in the education of future Jefferson
medi cal students as the technology improves and better
hyp ermedia learning programs are produced. ,.
Will Tomorrow's
Journals Be Electronic?
John J. Gartland 5'44
T he continuing growth of compu ter capacity and in formationtechnologies has unl eash ed digital streams of sound, images ,
and text into cyberspace, revolutionizing the way physicia ns access
and diss eminate information . Electronic storage is fast replacing
paper as the most cost-effect ive storage mechanism for information,
and digital archiving has obvious adva ntages over costly library
stack shelving. A logical response to thi s evolving and improving
technology is the deve lopment and use of wid e-area, compre-
hensive, networked information sys tems whi ch co nsti tute , in effect ,
an information highway (reference 7) . Stre tches of this information
highway lie along several networks, each with its own traffic.
Telephone lines, for example, carry co nve rsa tio ns and faxes . Cable
TV is now testing int eractive programs. Th e Int ernet , a globa l web
of computer connections, combines various networks to de liver
text, sound, and images. At Jefferson, the Int ern et helps to provide
and promote use of computer-bas ed learning programs among
faculty and students.
The Int ernet is the sum of tens of thou sands of computer-based
networks that are believed to int erconnect milli ons of individual
computer users . The future of Int ernet communica tio ns is believed
to lie with too ls like World Wide Web (WWW) which permits
intuitive searches and extensive use of graphics. The World Wide
Web, a global communication and informat ion network, is the
fastest growing, graphics-rich subse t of the Int ern et , in addition to
being the most user friendly part of the netw ork. Software
programs called browsers allow users to move around from one
World Wide Web site to another. The communica tion and
information retrieval value of personal computers for physicians is
tied inextricably to the use of networks like Int ernet and World
Wide Web (6).
Wi th appropriate software programs, ph ysician s can now consult
extensive databases maintained by the Nation al Library of Medicine
in order to stay current with rapidly changing medical know ledege.
Electronic mail (e-mail) , the simples t and most basic use for the
Internet, provides physicians with an easy means of communicating
and exchanging information with co lleagues and pat ients. E-mail is
used extensively by researchers and medical specialists for the
exchange of new information. Clinical practice guidelines,
sponsored by th e Agenc y for Health Care Policy and Research, are
available on CD-ROM in medical libraries and can be read by
physicians on their own computer sc reens, can be print ed for office
use , and can be downloaded on their own computers. More
complex is telernedicine, the use of telecommunicat ion
technologies to pro vide medical information and medical services
by remote electronic consultation (3). As this technology evolves , it
is believed that ph ysicians will be able to int erview, examine and
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advise patients who are at remo te sites, and will allow physicians
access to electronically store d medical records, x-ray examina-
tions, and laboratory results . The technology will eventually
allow insta nt access to on-line libraries of med ical inform ation,
treatment algori thms, and pati ent instruc tional mat erial, and will
provide com puter-based scheduling for referrals to specialists and
allied health perso nnel.
A logical extension of e-mail, the point of entry for exploiting
more sophis ticated resources, is electronic publishing. The
Internet has the capabili ty to speed up information flow and can
convert it from a one way channel to live interactive forums.
Publishers of on-line medical jo urnals lure authors with the claim
that the informat ion contained in their articl es will be dissemi-
nated immediately and can be available everyw here with a few
computer keystrokes . The real probability exists of an increasing
number of medical journals appearing on-line in the near future.
These new electronic meth ods of disseminating clini cal and
researc h information are beginning to pose a challenge to the
preeminence of traditional print medical
jo urnals which, admittedly, are mu ch
slower in getting published information to
their readers.
The driving push toward electron ic
pub lishing is econo mic, as well as the
allure of the new technologies that make it
possible. The deputy editor of The British
Medicaljoul11a l, for example, is qu oted in
the July 31 issue of American Medical News
as saying that it is incre dibly expensive and
inefficient to commun icate research results
on paper. Libra ries are buying fewer pr int
journals even as more become available,
thanks to the increasing complexity of
biomedical research, and the development of new medical and
surgical subspec ialties. The pr ice of print jo urna ls is increasing
steadily, up an average of 10 percent every year since 1986.
Consequent ly, major acade mic centers have bought 0.5 percent
fewer jo urna ls every year since 1986. So, with paper costs rising,
print journal advertising revenues declining, and subscri ption
price increases forcing libraries and physicians to cut back on
print journal purchases, even as they continue to demand the best
and most current medical information, are on-line medical
journa ls the electro nic answer for physicians?
Propo nents of electronic pub lishing believe biomedical
publishing is now at a watershed (1) . They believe print jo urna ls
have been rendered almos t obsolete by these evolving comm uni-
cation techn ologies. They point out that original work and its
acquired criticisms, plus supporting documents, charts ,
references and data bases are now access ible on a computer
scree n throu gh a ser ies of mouse clicks. Franklin Electroni c
Publishers, Inc. of Mount Holly, New Jersey, for example, is now
the world's largest publisher of electronic books. This publisher
has sold more than 10 mill ion books, including dictionaries and
medical, legal, and financial reference works. Periodi cals on the
Intern et increased tenfold between 1991 and 1995 and now
number jus t over 1,000. Five to 10 new titles app ear almost daily,
and many major book and jo urnal publishers are preparing to
convert hundreds of existing publications to an on-line format. At
present , medical journals make up on ly a fraction of the total
number of on-line journals, bu t this number is expected to increase
qui ckly in the near future. Experts attr ibute the explo sion in
electronic publishing to new powerful software programs that make
tapping the Intern et as easy as poin ting and clicking on a computer
screen. Electronic publishers say their goal is to go to full text on
the Intern et , including hypertext links to other resources.
Hypertext , a type of hyperlin k, lets users jump from one source to
ano ther, even if the other source is a computer on the other side of
the world.
Publishers of print medical jo urnals are far from surrendering the
field and are busily reorganizing themselves to ward off more
challenges from electronic journal publi shers
(8) . Some print publishers have responded to
the electronic cha llenge by diversifying to
produce other materia ls, such as practice
management periodicals, medical newsletters,
and abs tracts of new biomedical information .
Annals of Intern al Medicine, for example, is
collabora ting with The British Medicaljournal
to produce a publication titled Evidence Based
Medicine, which dis tills information from 50
top print medica l journals.
Other pri nt medical jo urnal publi shers are
strengthening their operations by acquisi-
tions, mergers, and ama lgamations. For
example, Wolters -Kluwer acquired]. B.
Lippin cott and Raven Press, then joined them together. Britain's
Reed joined Holland's Elsevier, and Germany's Holtzbrinck bought
70 percent of Macmillan , owners of Nature and Nature Medicine.
These moves signify a new era of collaboration among publishers of
pr int medical jo urna ls designed to lower competitive barriers
between them and to make their positions stronger in face of
increasingly stronger challenges from electronic publishers.
Physical scientists are acknowledged generally as being the first
within the scienti fic community to ado pt electronic publi shin g.
Physicists, for example, have been communicating and conducting
research electro nically since 1991. Most information experts,
however , believe physicians and some biomedical researchers will
be slower to accept electronic publi sh ing because train ing in the
use of such techn ology amo ng medical professionals is limited .
Publishers of medical pr int journals tend to believe that the open-
ended system that seems to work for physics will not work as well
for health care where sloppy studies and flawed conclusions could
compro mise patient care. Not un expectedly, most publi shers of
print medical jo urna ls oppose the freewheeling, unrefereed
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the free-flowing Internet. Another question medical investigators
must consider is whether posting preliminary findin gs on the
Internet constitutes prior publication, thus making a subsequent
printed text ineligible for publication in a peer reviewed print
journal. The New England Journal oj Medicine announced in June
1995 that it now considers reporting research results on the
Internet to be prior publication, similar to publi shing the data in
any other format (2). However, as before , research results can be
presented at scientific meetings without that type of presentation
being considered prior publication.
A deep concern physicians should have about electronic medical
journals is the public's increasing abilit y to access such information
on the Internet, sometimes even before physicians themselves have
had a chance to digest and evaluate the same information . At
present, it is not likely this medical information receives much
objective review before its presentation on the Internet , thus
rendering the accessing publi c virtually clueless as to the validity of
the information the y have read . Because the ult imate purpose of
information publi shed in either print or
electronic medical journals is to improve the
care given to patients , it is vitally important
that the information presented to readers be in
the simplest and clearest terms possible. The
information must be accurate and valid in itself
and be presented clearly and logically so that
physicians who read eith er print or electronic
journals are in no danger of misinterpreting or
misunderstanding the inform ation.
One of medicine's professional st rengths is the
existence of editorially independ ent peer
reviewed medical journals in which physicians
and scientists, the public, the media and
patients can put their trust (4). Readers can
believe that what they read in these publica-
tions will be as correct as it is humanly possible to be at that time.
The practice of editorial peer review is based on the social habit of
relying on consensus to validate action. The scient ific community,
including medicine, relies on the peer review process as the
acceptable way of judging the validit y and study design of a
reported work in order to determine whether the reported resul ts
are valid and significant enough to be add ed to the permanent store
of recorded information. The ultimate issue in the peer review
process is the quality of the scientific literature and the degree of
faith it deserves from readers and researchers. However, it can not
be denied that the traditional peer review process delays the
publication of medical information in print journals, a delay that
proponents of electronic publishing claim is unnecessary.
Critics of the traditional peer review process can be expected to
favor electronic medical journals. In addition to the delay it causes
in the time to publication, these critics object to traditional peer
review on the ground that it tends to allow onl y conventional work
into the print medical journals, and tends to discourage those they
] ".'a~
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Anoth er drawback is that on-s creen
reading is 20 to 30 percent slower and
much less comfortable than print reading
at the present time because of screen
problems such as glare and flickering
images. Screen reading will have to be
improved if electronic medical journals hope to attract a large
number of physician readers.
approach of electronic publishing, particularly when it is realized
the public has full access to the Internet. Many print medical
journal editors believe the scientific quality of what is now
pouring into cyberspace is too uneven to permit wholesale
acceptance of electronic publishing in its present state of
development. Many medical researchers, however, are clamoring
for change and demanding a more rapid and efficient way of
disseminating their study results. Some publishers of electronic
medical journals are calling on medical researchers to bypass the
comparatively slow peer reviewed journals entirely and publish
their findings directly on the Internet. Electronic publishers claim
their new formats serve physicians and medical researchers better
because they are faster, cheaper, and more widely available, and
the publications can be indexed and searched electronically.
Before cancelling their print medical journal subscriptions in
favor of electronic ones, physicians would do well to balance the
present drawbacks and disadvantages of on-line medical journals
against the advantages promised by electronic medical journal
publishers. One present drawback is lack of
reader ease in extracting the sought after
information. To read on-line medical
journals physicians need computers,
modems, and appropriate software
programs, plus new skills and a lot of
patience to access the sought-after
information. This drawback becomes more
obvious when one considers how easy it is
to extract information from print journals.
etwork enthusiasts talk excitedly about creating a garden on the
Internet where freedom of speech would thrive. This kind of talk
should raise a caution flag to physicians because, if this garden
comes to full bloom, how will physicians be able to distinguish
good patient care information from bad patient care information
on the Internet? Technology promises more and more
information for less and less effort, but this trade off can be a
dang erous concept for physicians who must rely on the validit y
of the medical information they receive in order to care for
patients appropriately. In the final anal ysis, it will come down to
the integrity of the electronic medical journal to ensure the
validi ty of the information it disseminates. At this time , it does
not app ear likely that electronic medical publishing has advanced
to the stage of being able to provide that assurance.
Oth er questions arise about electronic medical journals such as
how they will be archived and how copyrights are protected on
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consider to be trul y significant innovators or original thinkers.
Proponen ts of electronic publishing claim that publishing on
the Internet does not necessarily mean abandoning the peer
review proc ess. However , physicians should note that as of May
1995 , less than one-quarter of on-line journals described
themselves as being peer reviewed (1). At this time , it is not
clear how electro nic journals claiming to be peer reviewed
accomplish this task. This particular topic will be addressed in
depth at the International Congress on Biomedical Peer Review
and Global Communications, hosted jointly by TheJouma l oj
the American MedicalAssociationand The British Medical Joumal
to be held in Prague in September 1997 (5) .
There can be no doubt that the Internet and the World Wide
Web offer tremendous opportunities to physicians for
expanding their knowledge bases . CRISP (Computer Retrieva l
of Information on Scientific Projects), a quarterly CD-ROM
from the U.S. Public Health Service , allows users to ob tain
cur rent information on federall y supported biomedical research,
even before the research results app ear in the published
literature. A new home page on the World Wide Web provides
information about proposed and ongoing clinical trials . This
service helps select patients for clini cal trials by screening some
candidates and by listing participation criteria.
Physicians should not be surprised, therefore , that electronic
medical journa ls are emerging on the Internet. It seems a safe
assumption that the number and importance of electronic
medical journals will increase and expand over the next few
years. At the present time , how ever , it seems wise for physicians
to remain caut ious in their acceptance of information contained
in electronic medical journals until these journals can provide
them with better assurances that the information they publish is
both accurate and valid. The concern physicians should have
about the transfer of any med ical information is, and remains ,
that the information being transferred no t be capa ble of being
misinterpreted nor misunderstood, nor carry the potential for
harm to patients. Until electronic medical journals can provide
that assurance, ph ysician reliance on them for medical
information should be cautious and limited.
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Computers in Patient Care:
Jefferson Health System Cont inues
to Upgrade Information Technology
H ealthLlNK, the Jefferson Health System's ini tiative toupgrade and standardize its information technology, is
making rapid progress. The ultimate goal is the capabili ty to
follow patients through the care delivery system and have
access to complete information about them , wherever and
whenever they receive care. The technology will combi ne
cos t and care information and create data bases needed to
iden tify varia tions , define best practices, and establish and
manage qu ality and cost. Thomas Jefferson University is
working closely with Main Line Health. a partner in the
Jefferson Health System , to coordinate initi atives needed for
JHS to operate as an int egrat ed care delivery sys tem. Key
aspects include:
Health Services Network Connectivity
Expanding the computer network will ensure that employees
can easily and quickly access information. Cabling is being
overhauled, and locations are being determined for wor ksta-
tions. Major new electronics equipment is being evaluated
that will provide increased network speed and support more
network "traffic."
Common Patient Registration
A common patient registration is key to increasing patient
convenience and satisfa ction , and improving the accuracy of
information as it is used to treat patients across sites and
settings . Currently patients register at each Jefferson site;
un der a com mon program they will register once and the
information will be available at all sites.
Physician Practice Management
The Physician Practice Management Information System will
provide the ph ysician office with a billing and accounts
receivable tool to manage financial data , optimize collections ,
and generate comprehensive reports. It will also provide
required managed care capabilities including eligibility,
referral , and co-pa y management.
Order Entry, Results Reporting, Resource Scheduling
Order entry, results reporting, and resource sched uling have
been identified as strategic proj ects to effectively coordinate
care and servic es throughout the Jefferson Health System. It
will be possible to easily order tests and other clinical
services, quickly obtain results, schedule clin ical resources,
and ensure a continual record as pati ents are treated at all
phases. 111
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Female Alcoholics More
Adversely Affected by Alcohol
Trapping of LDL Pinpointed in
Development of Clogged Arteries
AJefferson study indicat esth at fem ale alco ho lics have
a grea ter propensity to alcoh ol-
induce d car diac dam age than
male counterparts.
In a stu dy in th e July 12 j ournal
of the American Medical
Association, research ers from
Jefferson and th e University of
Barcelon a in Spain conclude
that the heart of a wo ma n is
more sensi tive to alcoho l abuse
than that of a man.
In th e study, which was led by
Emanue l Rubin , M.D., the
Apo nte Professor and Cha irma n
of Pathology, Ana tomy , and
Cell Biology, invest igators
assessed th e streng th of 150
male and fem ale alcoholi cs by
conduc ting muscle biopsies ,
echocardiog raphs , car diac
angiographies, tr eadmill-
exercise elec trocardiographies,
and additional lab stu dies.
It was observed that female
alco ho lics had the same
prevalen ce of ca rdiomyo pathy
as male alcoho lics , despite
having cons umed far less
alcoho l. This finding con tra -
dicts a wid ely held belief am ong
medical professionals th at few
female alcoho lics ge t card iomy-
opa thy . Dr. Rubin emphas izes
that degen erati on of th e heart
mu scle requires lon gstanding
chronic alcoho lism. By contras t,
light-to-moderate drinking ma y
exe rt a protective effect agains t
coronary artery disease and
heart attac ks .
"Since th e majority of
alcoho lics are men , it is not
surprising that most cases of
alcoho lic cardiomyopathy and
skeletal myopathy have been
reported in men ," says Rubin .
It was also noted that the
threshold dosag e level for th e
development of myopathy and
cardiomyo pathy is cons iderably
lower in wome n than in men .
In addition , th e investi gators
obse rved that for a given
amount of alcohol , th ere was a
grea ter decrease in heart
contrac tion streng th in female
alcoholics versus participating
mal e alcoh oli cs. The
research ers plotted on a graph
th e total lifet ime consumption
of ethano l per kg of bod y
weight aga ins t the left
vent ricular ejec tion fract ion (a
measure of th e heart's strength
during con trac tion) for 50
alcoho lic wo me n and 100
alco ho lic men . The slope of th e
lin e for women was consid-
erably stee per than th e one for
men , indicating that for th e
same dose of alcohol, th e hearts
of female alcoholics were more
severely damaged .
"Despite th e fact that the
average am ount of alcohol in
fema le alco ho lics was only 60
percent that of mal e alcoh olics,
cardiomyopathy and myopathy
were as commo n in the females
as in th e mal es. This, together
with th e more pronounced
resp onse of th e heart to a given
dose of alco hol, indicat es that
wom en are more sens itive than
men to th e toxic effects of
alcohol on stria ted mu scle,"
says Rubin.
The re are a growing number of
Significant studies that describe
susceptibili ty differences
between men and wom en to the
toxic effects of alcohol. Wom en
appea r to be at grea ter risk for
developing alcoh olic liver
disease and to have a grea ter
vulne rability to brain damage
than mal es. JI
I n exa mini ng th edevelopment of athe ros cle-
rosis , resear ch ers at Jefferson
Medical College and th e
College of Physicians and
Surgeons of Columbia
University hav e found a key
event in early lesion
formation, nam ely, th e
trapping or retention of low
density lipop rotein (LDL), or
"bad" cho les terol with in th e
vesse l wall. The resulting
accumulation of LDL is an
absolute requirem ent for
developing atherosclerosis.
Th e findings we re publish ed
in a recen t edition of
Arteriosclerosis & Thrombosis.
"Reten tion of LDL withi n th e
arterial wall, and th e respo nse
of art erial tissu e to th is
retained mater ial , con tro l eac h
person 's development of early
atherosclerotic vascular
disease," says Kevin].
Will iams , M.D., Associate
Professor of Medi cin e at
Jefferson and lead author of
the study .
Risk facto rs for heart disease
explain only half of th e
variation am ong individuals
in th e development of heart
disease. For example, peopl e
with similar blood cho lesterol
concentra tions and blood
pressures can have di fferent
exten ts of disease.
Th e Jefferson -Columbia
collabo ra tion highlights th e
importance of focusing on th e
tenden cy of a person 's arte ries
to trap or retain LDL. Finding
a famil y hist ory of heart
disease may indicate that
family members' arte rial tissu e
is more likely to retain LDL,
even if th e same plasm a
conce ntrations of LDL wo uld
not cause ex tensive athero-
scleros is in individuals with
other gene tic backgrounds.
"Right now we have fairly
good, pr eliminary information
about how and why retenti on
of LDL occurs in arterial
walls ," s tates Willi ams.
He also acknowledges that
mu ch remains to be learn ed
abo ut retenti on . It is still
unclear how factors regarding
retenti on are different in
individua ls with posit ive
family hist ories for heart
disease. He believes such work
could lead to new stra tegies
for prevention and treat ment.
Two other hypotheses that
have been prop osed to explain
th e onset of atherosclerosis are
addressed by Dr. Williams and
Ira Tabas, M.D., Ph.D.,
Associate Professor of
Medici ne and Ana tomy an d
Cell Biology at the College of
Physicians and Surgeons of
Co lum bia University, who co-
authored th e study.
"One theory proposes that
shee r stress on th e branch
points in th e arteries produces
molecul ar cha nges that lead to
lesion form ation ," he exp lains .
"Upon closer exa mina tion , it
is evide nt th at shee r stress is
not an esse n tial contributor to
hea rt disease because lesions
can develop in nonbran ch
poi n ts of arteri es as well. "
Williams and Tabas also cite
th e oxi dized LDL hypothesis
in their article. Ox idation of
LDL is an unfavorable
biological process whi ch can
genera te byproducts
stimulating the grow th of
lesion s that block arte ries. But
continued at li ght
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Molecule Essential for Cell Growth and Division is Discovered
I n a basic biologi cal sciencedevelopment, researchers at
the Jefferson Cancer Institute
have identified a new protein
as essential for cell grow th
and division . The new
protein , PISSLRE, apparent ly
becomes activated during the
phase of the cellular life cycle
known as G2 and con tinues to
exert its effects unt il the M
phase. Expression of PISSLRE
by cellular DNA is essential
for human cells to grow and
divide properly. The finding is
presented in the September 15
issue of Cancer Research.
Jefferson researc he rs have
been studying the rela tionship
between proteins and the
cellular life cycle in order to
better understand a variety of
diseases, including cancer,
and to design new drugs
agains t them. "We hope tha t
as we learn more about the
cell cycle, we can app ly our
findings to the development
of drugs that only targe t
cancer cells-with no effects
on normal cells," says
Anto nio Giordano , M.D.,
Ph.D., Assistant Professor of
Microbiology and
Imm unology. "As it stands ,
chemo therapy is toxic to
many other cells in the body
other than tumor cells."
Giordano and othe r investi -
gators identified the PISSLRE
protein as essential for
mammalian cells to move
from the G2 stage to the M
stage.
Cell-cycle regulato ry proteins
are of Significant therapeuti c
interest because the molecules
are expec ted to provide a basis
for develop ing potent drugs
that act more specifically than
those currently available.
Regulatory pro teins are only
present in dividi ng cells and
are only activa ted at part icular
times within the cell cycle .
This sho uld allow for the
development of drugs that
only targe t proliferat ing cells,
with no side effects to resting
cells. Chemotherapy, in
contrast, acts nonspecifically,
and is toxic to normal cells. In
addition, different CDK
molecules and other cell cycle
regulatory proteins are
present in tumor cells than in
normal cells, making the
targeting of tumors a
possibilit y.
Dr. Giordano was the first to
find a dir ect ph ysical link
between cell-cycle regulation
and cancer. His latest research
builds on th is body of
knowledge. His work
demonstrates that in order for
human cells to transform and
become cancerous , oncogenes
in terac t direc tly with the
cyclin and CDK molecules,
effectively deregulating the
cell cycle. Normally in
humans, if altera tions in the
cell growth or division
process are sensed , cells are
induced by their DNA either
to stop dividing and become
inactive, or , if they have
suffered dam age, to und ergo
apoptosis. Wh en errors in the
chromosomes are presen t, the
genes may produce abnor mal
cyclins and CDKs that lead to
a chain of molecular events
resu lting in cancer.
Abnormali ties in the cyclin
and CDK molecules have been
found in a variety of human
cance rs.
For exam ple, Giordano's
laboratory recently
demonst rated that a defect in
the RB-2/p130 gene may
result in a genetic predispo-
sition to nasopharyngeal
cancer when exposed to
certain environmen tal agents.
The researchers also showed
that this gene maps to a
region of the human
chromosome that is
frequently missing in a
number of human cancers ,
such as breast, ovarian, and
prostate cancers. III
contillued from left
Mammograms Are Cost-Effective
and Significant~ Reduce Death Rate
before Significant oxida tion of
LDL can occur, the LDL must
first be retai ned in the arterial
wall , which sequesters it away
from antioxidants in plasma.
The doctors bot h agree that
an important result of th is
research is the added support
it provides to red ucing LDL
levels in the blood. Humans
or animals with ext remely low
plasma concentrations of LDL
seem to be spared atheroscle-
rosis despi te other risk
factors, even a positive
family history.
T he medical community'songoing controve rsy over
whether mammograph y is
recommended for women age
40 to 49 has left many
wonde ring, is it necessary?
Safe? Wo rth the expense?
Yes to all three ques tions,
acco rdi ng to Jeff research
pub lished in the Nove mber 15
issue of Cancer.
The study takes a look at
a recent meta-analysis of
seven rando mized trials.
The combined trial results
show that mammography
screening for women age 40
to 49 significant ly reduces the
mort ality rate.
As far as risks , they are
negligen t or non existent
compared with the benefit
from screening, notes Stephen
A. Feig, M.D., Professor and
Director of the Breast Imaging
Center and aut hor of the
study. No woman has ever
developed breast cancer due
to mammography, even with
exams at doses man y times
higher than the cur rent
dose used .
The total cost of screening
women age 40 to 49 run s from
$6,930 to $13,413 per year of
life expectancy gained,
including downstream costs
such as core or excisional
biopsy for women \ ith a
suspicious abn ormality.
Mammography screening itself
is more cost-effective than
many other accepted
lifesaving int erventi ons for
women age 40 to 49, such as
cervica l cancer screening or
osteoporosis screening, point s
out Dr. Feig. III
19 I E F F E R S O N Medical C oll e g e Al u mni B u l l et i n D e c em b e r 19 9 5
RESEARCH
Antisense DNA Therapy Prevents
Burkitt's Lymphoma Tumors in Mice
Dr. Wickstrom with a molecular model
Researchers led by EricWic kst rom, Ph.D.,
Professor of Pharmacology,
have prevented tumor
formation in mice predis-
posed to Burkitt's lymphoma .
In the longest test of
antisense DNA therapy in
animals to date, three-week-
old mice witho ut tumors
were treated for six weeks
with a gene- targeted drug.
The study , which appea red
in the September issu e of
Molecular Medicine,
represen ts the first
demonstration of an tisense
DNA therap y to prevent
tumor onse t. Th e work
sugges ts that similar gene tic
therapy might one day be
used to prevent Burk it t's
lymphoma in humans with
a genetic pr edispositi on to
the disease.
For some diseases cause d by
defective prot eins, Jefferson
gene tic researchers may be
able to block the cell's ability
to make the protein .
Antisense DNA drugs wo rk
by binding to RNA messages
from genes, so that their
genetic code canno t be read.
Antisense DNA fits up
agains t its target like a
matching puzzle piece. On ce
bound, the drug prevents the
gene from being copied, or
the message from being read .
The term antisense has been
adopted because the RNA
message from a gene carr ies
the gene tic code for a speci fic
prot ein to be read in the
correc t sense, and the
antisense DNA mu st have
the oppos ite, or anti-, sense,
in order to bind to the
gene copy.
Dr. Wickstrom and
co-investigators used
transgeni c mice engineered
to carry a chromosomal
translocation that causes
Burkitt's lymphoma. Th e
rearrangements cause rapid
pr oliferation of blood cells .
Th e mice almos t always
develop lymphoma tumors
by 16 weeks, and die
soo n after.
In the expe riment, 95
percent of the control mice
that did not receive the
antisense DNA drug
developed tumors by 16
wee ks. In contrast , 75
percent of the mice that
received the drug were
tumor-free at 26 weeks-
17 weeks after treatment
had ended-sugges ting the
establishment of long-term
resistance. "The rarity of
tumor onset after the end of
treatment sur prised us," says
Dr. Wickstrom.
The goal of nucleic-acid-
based therapeutics , like the
one used in this study , is to
turn off the mutated genes
that cause cance r. When the
gen es are turned off, they
can no longer make the
pr otein products that lead to
disease. This approach
attacks the initial cause of
cance rous growth. In
contrast, curren t cance r-
che mo therapy drugs are
designed to stop the activity
of the protein s.
The DNA used in the
antisense drug in this study
consists of only 15 lett ers of
genetic code that correspond
to a IS-lett er target in the
c-myc gene , which contains
over 4000 lett ers of code .
Antisense DNA binds to the
c-myc RNA messages so that
they can no longer express
the prot eins that lead to
un controll ed blood -cell
proliferation and cancer.
Altho ugh the Jefferson
resea rchers were un able to
inactivate expression of c-myc
in established tumo rs, the
an tisense DNA did prevent
tumor initiation.
Th e research ers hope that
tumor resistan ce might be
similarly induced by antisense
DNA the rapy in hu mans who
have the same chromosomal
rearrangements. In addi tion
to Burkitt's lymphoma, suc h
a therapy might be applied
against many types of
lymphomas, multiple
myeloma, breast cancer,
and colon cancer.
Wickstrom expects clinica l
trials to begin in approxi-
mately on e year. The
gro up 's next experime nt will
reveal whether long-term
pro tection again st lymphoma
in mice dep ends on
activation of the immune
system.
Burki tt's lymphoma is found
in higher rates in central
Africa, but is reported from
ma ny other areas. The
Eps tein-Barr viru s, a herpes
virus , has been isolated from
Burki tt's lymphoma tum ors
and has been impli cated as a
causa tive agent in about 25
percent of cases. Th ose
afflicted with the disease
express a characteristic
chromosome crossover
between chromosomes 8 and
14, and more rarel y, 8 and
22, and 2 and 8. Each of
these translocations causes
production of the c-myc gene
in large amounts, leading to
tumors. If)
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TEACHING
Medical Humanities in the Jan Plan:
Transforming Practice into Healing
Emilie S. Passow, Ph.D., an
Assistant Professor of English
Literature at Swarthmore
College, teaches in Jeff erson's
January mini-semester. Her
reflections on this curriculum
are adapted below from the
jefferson Student Examine r.
Over the past two decades,tension between the
increased use of advanced
medica l techn ology and a
growing concern for the
quality of clinica l enco unters
has stimulated a reassessment
of health care train ing and
delivery in many insti tuti ons.
The issues are far-reaching.
Wha t impac t, for example, do
these new technologies along
with rising pati ent demand for
greater involvement in health
care decisions have on the
physician 's ro le? How can
physicians develop empathy
without losing the profes-
sional distance necessary for
their own and their patients'
well-being? How may gender,
race , ethnicity, and values
affect the expec tations that
patients and physicians bring
to medical situa tions and the
choices that they make?
Expanding factual knowledge
and tighter budgets make the
challenge of being a ph ysician
even more complex than it
inh erently is.
At j efferson Medical College,
the j an Plan min i-semester
includes an elective in
literature and medicine to
help studen ts explore the
emo tional and ethical
dynamics involved in current
medical practice. Dramatizing
conflicts that patients,
families, and personnel are
likely to experience, imagina-
tively inviting the reader int o
the consciousness of
charac ters wh o face pain,
disability, even death ,
literature, art , and social
science ethnography that deal
with suffering expose its man y
layers and possible responses
in richly textured , nuanced
ways that scien tific descrip -
tions and factual case studies
alone canno t pro vide. Literary
pieces, in particular , foster an
appreciation of how the very
language used to explain
anything, medical or
othe rwise, itself both reflects
and shapes our percepti ons of
the subject.
The medical humanities
course I have taught the past
three years, "Perceptions of
the Human Body," has
focused on experiences in the
gross anatomy lab , because
dissecting the human body
initi ates students into
kn owledge of the body and
the ethos of medicine through
an experience radically
distinct from other modes of
learning and from what other
human beings usuall y do. A
privileged , ambiguous place of
dr ead and wonder, of disgust
and gratitude, the gross
anatomy lab might, in effect,
be seen as the cruc ible of a
ph ysician 's character. The
attitudes and strategies
developed toward dissection,
many assert, set the tenor and
direction for att itudes and
methods of care giving and
adaptation to crisis
throughout a medical career.
The texts we discu ssed in the
course revolved around this
connec tion. In wha t way is
the cadaver the first pati ent?
How can one handle the
confron tation with mort ality,
including one 's own, implicit
in handling a cadaver? To
whom does the bod y belong
and how do different views of
ownership underlie various
ethical positions and
emotional responses to
medical intervention and
death? Deformity and beauty:
how can they be conceptu-
alized whil e maintaining
clini cal professionalism?
What demarcates pati ent and
physician perceptions of
illness and its mean ing? What
is the connec tion between the
pati ent's cha rts and the
pati ent, between the ph ysical
body and life itself?
Teaching these courses is
satisfying, yet frustrating
precisely because discussion
generates sensitive and illumi-
nating insights from the
students. I often leave these
seminars feelin g that we have
barel y sipped an aperitif,
much less shared a meal. But
I know that the students will
have many years to simmer
this food for thought, and I
am convinced that our
readings and discu ssions will
influ ence clinical behavior.
Deeper understanding of the
pati ent-ph ysician relationship
is the ultimate rationale and
reward for including
humanities in a medical
education already strained by
traditional allotments of
academic time and turf. Such
understanding can be a
cornerstone of transforming
the practice of medicine int o
healing.
College, Hospital
Cited as Leaders
by u.s. News
U S. News & World Report• included j efferson
Medical College and Thomas
j efferson University Hospital
in its an nual rankings of
medical schoo ls and hospitals.
The college was rank ed
amo ng the top schools that
exce l in train ing primary care
physicians, based on two
equally weighted reputation
surveys of deans and
residency directors. In the
hospit al ranking, j eff rank ed
among the nation's best as a
center for AIDS treatment,
cardiology, gastroenterology,
geriatrics, gynecology,
neurology, orthopaedics,
rehabilitation , rheu matology,
and urology.
BOO K 5
Into the
21st Centu ry
David B. Nash, M.D.,M.B.A., Director of
Health Policy and Clinical
Outcomes, and Leonard M.
Rosenfeld , Ph.D., Assistant
Dean ofj efferson's College of
Gradua te Studies, are among
the four editors of Medicine
and Health Care Into the
2 Is t Century , pu blished by
the Pennsylvania Academy of
Science. 612 pages, numerous
cont ributors. $50.
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FACULTY EARN MA JaR AWARDS
Dr. Osterholrn .
his wife Anne ,
their daughter
Krlsty. her
husband lohn
Vaccarel li,
and daughter
Kait lyn
John F. Ditunno j r. , the
Michie Professor and
Chairman of Rehabilitation
Medicine and Director of the
Spinal Cord Injury Center,
characterized him as "open,
honest , and supportive." Dr.
Osterholm himself told the
audi ence, "In medicine there
are no longer personal
successes as much as collabo-
rative ones, not individual
stars as much as teamwork . I
am grateful to the suppor t
staff and residents and
patients who taugh t me as
much as I taught them-who
cha llenged me, and showed
me to be humble and to
understand suffering."
The portrait is the first in the
university's collection paint ed
by Mark Skolsky. - M.e.
Drs. D itunn o and Cotl er congratulate Dr. Osterholm
Clinica l Associate Professor
Bruce E. North rup, M.D.
explained to the portrait
present at ion audience that early
in his career Dr. Osterh olm
mad e the observa tion on which
his discoveries and patents
hinge: that following a stroke,
there is a crucial interval of
time during which measures
can be taken to minimize
permanent neu rological
damage (see the September
1995 Bullet in, page 17).
Jerome M. Cotler '52, the
Gord on Professor of
Orthopaedic Surgery and a
spine surgery expert , praised
Dr. Osterholm's spiri t of
"working alongside other
specia lists withou t the
int erference of ego or jea lousy. "
Osterholm Portrai t: A Collegial
Team Lauds One of its Members
Col-leagues
and friends
ofJewell L.
Osterho lrn,
M.D.,
Professor
and past
Chairman
of Neuro-
surgery,
presented
his portrait
to Tho mas
Jefferson
University on October 11.
,'~-1', ''\ ' - ~ . : .-' .. ,_.....::.;/
reno wned for
developin g the
world 's first
successful
artificial tendon
for reconstru ct-
ing severely
damaged
hands. The
Hunt er artificial .... _ - ""
tend on was targeted for cases in which
there was so much scar tissue that a
conventional tend on graft had little
chance of functioning. Unt il a new
tend on shea th form ed , human tend on
could not operate prop erly and would
not be sufficiently nourished. Inserting
the Hunter Tendon Implant permi tted
the scarred tendon bed to rebuild a new
sheath in response to tendon implant
gliding .
Christinc l.ni nc, M.D., M.P.H.,Assistant Professor of Medicine , has
been named a Picker/Comm onw ealth
Scholar by the Commonwealth Fund .
The award carries a two-year grant of
$100,000 to support her research on
patient knowledge followin g prima ry
care visits. Dr. Laine is an Associate
Editor for Annals of Intcmal Medicine.
Carl M.Mansfield
RO'63, Adjunct
Professor of
Radiation
Oncology, has
been appointed
Associate
Director of the
Division of
Cancer Treatment of the National
Cancer Institute in Beth esda, Maryland ;
he's responsible for the Radiation
Research Program.
D avid B. Nas h, M.D., M.BA. ,Director of Health Policy and
Clinical Outcomes, was present ed with
the Clifton J. Latiolais Honor Medal at
the meeting of the American Managed
Care Pharmacy Association. Dr. Nash's
recent activities inelud e being immediate
past chair of both the Center for Clinical
Quality Evaluation, a not-for-profit
research group in Washin gton , D.C., and
the Clinical Evaluative Sciences Council
of the University Hospital Conso rtium.
W illiam E. Staas jr. '62, Presidentand Medical Director of Magee
Rehabi litation Hospital, will serve a six-
year term as a Director of the American
Board of
Physical
Medicin e and
Rehabilit ation ,
and an
indefinite term
as Director of
the Medical
Advisory Board
of Bayada
Nurses , a
regional home health agency.
Gcrald B. Grunwald, Ph.D., Professorof Pathology, Anatomy, and Cell
Biology, has been invited to serve on the
Visual Sciences C Study Section in the
Division of Research Grants for the NIH.
Study sections review NIH grant applica-
tions, and survey the status of research in
their field.
l ames M . Hunt cr '53 , the DistinguishedProfessor of Orthopae dic Surgery , wasonored as a Pioneer in Hand Surgery by
the Internati onal Federation of Societies
for Surge ry of the Hand. Dr. Hunter is
E'Cl,a G. llitraya, M.D., PI,.D., arheumatology fellow, has been
selected by the Arthritis Foundation as
the 1995 McDuffie Postd octoral Fellow
for her research into how and why
collagen accumulates in excessive
amou nts in scleroderma. Dr. Hitraya was
judged the best applicant in basic science
nationwide for this award.
BCIlj amin Bachara ch '56 (beingcongratula ted above by Senior Vice
President and Dean joseph S. Gonnella,
M.D.) was Jefferson Medical College's
Distinguished Honoree at the National
Philanthropy Day celebration of the
National Society of Fund -Raising
Executives. He was also nominated to
honorary membership in the Alpha
Omega Alpha Honor Medical Society by
the AOA members from Jefferson 's Class
of '95. Dr. Bacharach is Associate Dean for
Admissions at the medical college, a
Clinica l Professor and Vice Chai rma n of
Surgery, and Chairman ofJefferson 's
Presiden t's Club (see page 25).
M arluce Bibbo, M.D., the WarrenLang Professor of Path ology,
Anatomy, and Cell Biology, received the
newly established George L. Wied
Lifetime Achievement Award in Cytologic
Research at the 12th Intern ationa l
Congress of Cytology. More than 1,300
cytopathologists from 60 count ries were
in attendance. Dr. Bibbo is also President
of the International Academy of Cytology.
L conard G. Gomella, M.D., theGodwin Associate Professor of
Prostate Cancer, has been named an
Editor-in-C hief of the new jo urna l
Techniqucs in Urology. This quarte rly
peer-reviewed journ al covers surg ical and
nonsur gical management of urologic
diseases. Among the memb ers of the
editorial board are Demetrius H. Bagley,
M.D., a Professor of Urology a t j efferson,
and Michael B. Chancellor, M.D., an
Assistant Professor.
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Dean Gonnella is Named the
AAMC Co-Chair of the LCME
Board Welcomes New Trustees
Alan B. Kel~, ESQ:
Appointed University Counsel
oseph s. Gonnella, M.D.,
Senio r Vice Presid ent for
cademic Affairs , Tho mas
jefferso n Unive rsi ty, and
Dean, jefferson Medical
College , has been elected the
Co-Chair of the Liaison
Committee on Medical
Educatio n (LCME) from th e
Associa tion of American
Medical Colleges (AAMC).
The LCME, of whi ch Dr.
Gonnella has been a member
since 1992 , is a partnership
betwee n the AAMC and the
American Medical
Associa tion. Dr. Gonnella
will serve as Co-Chai r
through December 1997.
The LCME is the acc rediting
agency for u .S. and
Canadian medical educa tion
programs. It is recognized
for this purpose by the U.S.
Secre tary of Educa tion, by
the U.S. Congress in vario us
health-related laws, and by
state med ical licensin g
board s. The AAMC and
AMA each appo int six
The Class of '99
223 first- year medical
s tudents selected from
11,694 applicants
out of a nationwide
medical school applicant
pool of 46 ,591 (i.e . nearl y
one-quarter of all st udents
apply to jefferson)
the freshmen come from
26 states and on e foreign
country, and from 91
different undergraduate
colleges
professional members and
one student participant
lO the LCME; the LCME
itself appoints two public
members; and a member
represen ts the Commi ttee
on Accredi tation of Can adian
Medica l Schools.
LCME accreditation is
required for schools to receive
federal grants for medical
education and to participate
in federal loan programs.
Students and gradua tes of
LCME-acc redi ted medi cal
schoo ls are eligible to take
the Uni ted States Medical
Licensin g Examina tion
(USMLE). Th ese graduates
also have unrestricted
eligibility to ent er residencies
approved by the Accreditation
Council for Graduate Medical
Education . Graduation from
an LCME-accredited U.S.
school and passing a national
licensin g examination are
acce pted as prerequisites for
medical licensure in most
states . -M.e.
96 are female , or
43 percent
age ranges from 19
lO 38
c:r 19 already hold mas ter 's
degrees and three hold
doctorates
11 students are part of
the Physician Shortage Area
Program that funnels
graduates to practice in
underserved areas
Seven new members havejoin ed the Th om as
jefferson Univ ersit y Board of
Truste es.
Robert Poole 1Il '53 was
elected one of the three
Alumni Trustees for j efferson
Medical College , and Rhonda
Karp, Ed .D. was elected the
Alumni Trust ee for the
Coll ege of Allied Health
Sciences. Dr. Karp has se rved
as Executive Director of the
Greater Philadelphia Health
Care Con gress and the
Greater Philadelphia High er
Educa tion Congress . She has
been a department chair in
j efferson's College of Allied
Health Sciences and fro m
1987 to 1990 was Exec utive
Associate to Lewis W.
Bluemle j r. , then Presid ent of
the University.
Other new tru st ees are:
Ben Burke Howell , Esq. is a
member of the business and
finan ce group in the law firm
Reed Smi th Shaw & McClay.
He is Vice Chair of the
Americ an Bar Associati on 's
subcommittee on commercial
and real estate lending. Mr.
Howell chairs the Planned
Giving Committee of
A lan B.Kelly,
Esq . has
been
appointed
University
Counsel
and a senior
officer of Thomas jefferson
University. Previously he was
Episcopal Community Services
in Phil adelp hia.
Charlesreua Meade , Esq.
practices civil law. She has
chaired the City of
Phil adelph ia Tax Review
Board . In 1993 she rece ived
the City of Philadelphia
Cita tio n for Outstanding
Contributions.
j olm A. Sa lvatore is a
mana ging partner of the L&M
Beverage Compan y. He sits on
the Board of Directors of
Prime Source s , a cho colate
ex trac t company.
Robert ScaJldoJle, Esq. has a
pra ctice encompassin g civil,
commercial, antitrust , and
cri mina l litigation. He is a
member of the Board of
Directors of All Pro Champion-
ships, Inc. and the Gib ralta r
Equi ty Growth Fund.
Cuyler H. WalJ:er, Esq.
spec ializes in busin ess and
health care law with the firm
Pepper Ham ilton & Sche etz .
He is a member of the Barnes
Founda tion Board of Truste es,
Chairman of the East
Marlborough Land Trust, and
a member of the Board of
Mana gers of the Philadelphia
Founda tion.
corpora te counsel for West
j ersey Health System. Mr.
Kelly rece ived his j.D. and a
master's degree in hospital
and health care adminis-
tration from St. Louis
Universi ty, and a master
of laws degree in trial
advocacy from Temple
University. IfI
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DISTINGUISHED SUPPORTERS HONORED
Professorship is Established by D r. and Mrs. Paul Bowers '37
Women 's Board Celebrates
its lODd, Year
T he Women's Board ofThomas j efferson
University Hospital celeb rated
its LOuth year at the j efferson
Ball it present ed at the Hotel
Atop the Bellevue. The
Women's Board prom otes the
hospital , and brings state-of-
the-art care and comfort to
patients , by support ing projects
proposed by the hospital
administration. Among the
board's ongoin g programs is
the Penny Wise Thrift Shop . 111
December 1995
Enjoyi ng the Dinner for Class Agents and Reunion Chairmen
on September 18 are. above. lerome I. Vernick '62
and University President Paul
C. Brucker. M.D.
and. at right.
Stanton N.
Smullens '61.
lames W. Fox IV
'70 . and Burton L.
Wellenbach 1'44 .
S. Gon nel1a , M.D. adds ,
"We cannot push ahead in
our efforts to teach and to
relieve hu man suffering
without ph ilanthropy such
as th is. We are grateful for
the opportunities this
professorship affords ." 111
Dr. Bowers's record of service
has been paral1eled by Mrs.
Bowers's many contributions
on the Women's Board and
the Faculty Wives Club.
"The new pro fessorsh ip is a
prime example of the in terest
our alumni and the ir families
take in the medical college,"
says Pau l C. Brucker, M.D.,
President of the University.
"We could not sus tain
our efforts to cure disease
witho ut this support from
individuals who care abo ut
jefferson and its mission."
Senior Vice President for
Academic Affairs, and Dean
of the Medica l Col1egejoseph
and President of its Medica l
Staff. He also became
President of the Obstetrica l
Society of Philadelp hia . A
member of jeff's clinical
faculty , he was honored by
the presentation of his portrait
to the university in 1982.
JEFFER SON M edic al College Al umni Bulle tin24
Bowers wen t on to serve as
Chief of the Section at the
Philadelphia General Hospi tal
At the President's Club Dinner,
where the professorship was
announced, Dr. Bowers
reminisced about his long
career at jeff and declared, "I
am so glad to be here toda y
and able to give this profes-
sorship to this fine medical
college ." He received a
tremendous round of app lause
for his and Mrs. Bowers's
exceptional generosity.
After graduation from the
medic al col1ege and an
internship here, Dr. Bowers
completed a residency in
Chicago, then returned to jeff
to join the practice of
Thaddeus L. Mon tgom ery '20,
who was later Chairman of
Obstetrics and Gynecology.
T he creationof the Paul
A. and Eloise B.
Bowers
Professorship in
Obstetrics and
Gynecology has
been mad e
possible by the
support of these
superbly loyal
jeffersonians. A
member of the
Class of '37, Dr.
Bowers has
served as
President of the
Alumni Asso-
ciation and as an
Alumni Trustee
of Thomas
jefferson
University. Mrs. Family members look on as Dr. Brucker (right) announces the professorship donated by Dr. and Mrs. Bowers.Bowers is a past
President of the
Women's Board of Thomas
jefferson University Hospi tal,
and of the Faculty Wives Club.
President's Club Celebrates Gifts
lack Farber. Chairman of the
Board of Trustees. presents the
Cornerstone Award to Mr. and
Mrs. M. lames Termondt. who
represented the Falk Trust (Mr.
Termondt is its administrator) .
fj, ,3, .~(~,
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Dr. and Mrs. Kel ly with Dr.
Brucker. Mrs. KcI !y holds the
goldheaded physician's cane
signitying a Fellow of the
President's Club.
Rcmcmbcring
rhe latc Na nc)' S.
Groscclosc,
Executive Secretary
and then Executive
Director of the
Alumni Association
over the years 1966
to 1988 and the
donor of a genero us scholarship fund. are Senior Vice President
and Dean loseph S. Gonnella. M.D.. Edward H. McGehee '45.
and Ms. Groseclose 's brother Tyl er and his wife Maureen. Behind
them is a s imple plaoue that brings her contributions to mind.
he annual dinner for th ose
who support th e university
at th e Presid ent's Club level
was hosted in th e spec tac ularly
rehabbed Reading Terminal
Train Shed at th e Penn sylvani a
Co nventio n Center a few blocks
from campus. Each guest was
presented wi th a book abo u t
th e historic Reading Te rm ina l
and Market in period photos.
The President's Club is cha ired
by Benjamin Bacharach '56.
Highligh ting th e eve ni ng
was the an no unce me nt of
th e Paul A. and Eloise B.
Bowers Professor ship in
Obs te trics and Gynecology.
The 1995 Co rners to ne Award
was presented to th e Dr. Ralph
and Marian C. Falk Med ical
Research Trust. Dr. Fa lk , a
1907 alum nus, and his wife
wer e lauded for su ppo rti ng
gro undbreaking research at Jeff.
Th e trust th ey established made
a gran t of $ 1.5 milli on in 1992
th at pe rm itte d studies of th e
ALL- I gene by th e J efferson
Cance r Inst itute , and recently
th e trust mad e an ad d itional
S I .8 million gift to further
resear ch into other typ es of
cancer th at w ay be influen ced
by th e ALL-I ge ne .
ew Fellows of th e Presid ent 's
Club an no unce d at th e d inner
ar e Mrs. Flo rence E. Braun
(widow of William Braun '36) ;
Louis G. Kar eha '43; Dr. and
Mrs. James]. Kelly '39; F. M.
Kirb y II; Dr. and Mrs. Dan e A.
Mill er; Herman A. To lz; Martin
W ha len. Dr. and Mrs . Kelly
recently crea ted a trust
honoring John A. Carlson j r.,
M.D. , Director of Gynecologic
Onco logy. Th e trust will
provide funds for unrestricted
use in th e medical co llege .
Dr. Kareha is thanked by University
President Paul C. Brucker. M.D.
Central Pennsylvania Alumni Welcome Dean Gonnella, President McGehee
n a beautiful sunny Sunday ,
October 15, alum ni fro m
central Pennsylvania gathered to
welcome Senior Vice Pres ide n t
an d Dean Joseph S. Go nne lla,
M.D. and Lind a Gon ne lla, and
Alumni Assoc iatio n Presid ent
Edward H. McGehee '45 and
Carolyn McGehee . Hosting th e
brunch reception at th e Hot el
Hersh ey we re Raym ond C.
Grandon '45 and Doris Gra ndo n.
J eff grad uates from th e th irt ies
through th e nineti es we re
introduced by representatives
from th eir decad es: William
Ty ler Douglass jr. '37, Herbert
j ordan ]r, '46, Robert Bash or e }r.
'52, Bruce Goodma n '55, Mo r-
to n Rubin '67, Robert Pet ers III
'78, Mary Simmo nds HEM'80,
and J oseph locon o '93 . Many
othe rs se rved on th e receptio n
committee as well. The new
video abo u t J efferson Medi cal
Co llege , The Rise oj the Moming
Star, was viewed wi th grea t
in ter est. "We were warml y wel-
comed by our Hersh ey-area alumni ,
who tru ly sho wed us th eir best
hospitality," says Dr. McGeh ee, a
classma te of Dr. Grandon's. "There
was a spirit o f informa l fellowship.
Everyo ne enjoye d ren ewing friend-
ships , as well as learning about
developments at J eff. to
OBITUARIES
Hany F. Suter '3 1 di ed Marc h
3. He practiced general
medicine and cardio logy in
Penns Grove , Nj. He served as
Chief of Medicine at Memorial
Hospital, Salem Nj ,
1953-1968, and was
President , Salem Co unty
Medical Socie ty, 1938-1939.
He is survived by his wife,
Helen , an d two dau ght ers.
[ames ] , Grace '32 d ied j u ly
27 . He practiced family
medicine in Montrose , PA for
57 years, in additio n to
se rving as coroner's physic ian
and deputy in th e
Susque ha nna Co unty
Coroner's office . He served as
sc hool physician in Mont rose,
PA and Elk Lake , PA for ove r
50 years. Dr. Grace served
three term s as Preside n t,
Susque hanna Co un ty Medical
Society. There are no
immediate survivors .
Herman C. Rogers '32 di ed
july 10. He specialized in
chest diseases , wi th an
emphasis on tuber culosis. He
practiced at the Bonnie Burn
Sani tari um, Sco tch Plains , Nj ,
and Eagleview Sanita rium ,
Norristown , PA, and was
Superin tenden t and Medical
Direc tor, Sta te Tube rculosis
Sani tari um, Mt. Vernon , IL.
He later directed an occ upa-
tio na l healt h clinic a t th e
Germa ntown , MD facility of
th e Department of Ene rgy .
He is survived by his wife ,
Helen , a da ug hter, and so n
W illiam '65.
John L. Fanner '36 di ed july
23 . He practi ced general
surgery in Lancaster, PA and
served as Chief of th e Surgica l
Service, Lancaster Ge neral
Hospital. He was a fellow of
th e American Co llege of
Surgeons and a former
presiden t of th e Lan caster
City and Co unty Medical
Society. He is survived by four
daughters and two so ns .
Paul A. Leisawi tz '3 7 di ed
june 25. He pra cti ced genera l
surgery in Reading, PA. He
was o n sta ff, St. joseph
Hosp ital , Reading, PA and had
courtesy privileges at Read ing
Ge ne ra l and Co mmuni ty
Ge ne ra l Hospitals , Reading,
PA. He is su rvived by his wife,
Harriet , and two so ns .
Louis T. Gabriel j r. '40 died
May 7. A board-certified
gene ral su rgeon , he was on
s taff at Ashland Stat e Ge ne rai
Hospital , Ashland, PA. He was
a fello w of th e Ame rican
Co llege of Surgeons and
served as Medical Dir ector,
Ashland State Gen eral
Hospital , Ashland , PA. He is
survived by six sons .
Raymond E. Deily '42 di ed
june 26. He pr acti ced occ upa-
tion al med icin e in Bethleh em ,
PA from 1946 to 1963. He
was th en appointed Medi cal
Dir ector of th e Bethleh em
Stee l Co rpo ra tio n's plant in
Bethleh em , PA wh er e he
remaine d until retirem ent. He
is survivied by his wife, june,
and two daughters.
Allen E. Hamburg '43 di ed
june 27 . A board-certified
orthopaed ic surgeon, he
pr acti ced in Glenside, PA. He
was on s taff at Abing to n
Mem orial Hospital , Abing ton ,
PA and Holy Red eem er and
jeannes Hospitals,
Phil ad elphia, PA. He was a
fellow of th e American
Acade my of Orthop aedi c
Surgeons . He is survived by
two so ns and a dau ghter.
Thomas A. S'lafrey '43 died
Augus t 16. He practiced
gene ra l medicine and surgery
in Patte rso n , Nj and was a
member of the Essex
Co un ty,Nj , Medi cal Society.
He relocat ed to Sun City
Cen ter,FL after reti ring in
1974. He is survived by two
dau ghters and a so n.
Willia m A. Phillips '4 7 died
june 5. He was a dermatol-
ogis t and pr acticed with th e
Low er Cape Fear Dermatology
Group in Wilmington , NC.
He is survived by his wife,
Ph oebe.
Cha rles L. Saunders '50 d ied
May 3 1. He pract iced
obs te trics and gynecology in
Burlington, NC. He mad e an
ana to mical co ntri bu tio n of h is
bod y to th e Universi ty of
No rt h Carolina School of
Medi cin e, Cha pe l Hill , NC.
He is survived by a daughter.
Ma rtin D. Shid wla n '54 died
April 21. He prac ticed in ternal
medi cin e and cardiology in
Beverl y Hills , CA. He was on
staff at Ceda rs-Sina i Med ical
Center, Los Ange les, CA and
was Clin ical Professor of
cardiology at th e UCLA
School of Medi cine. Fro m
1973 until his death , he
se rved as th e director o f the
UCLA Extens ion Department
of Co n tinu ing Education in
Health Sciences, and as
Coordinato r of th e UCLA
Division of Co ntinu ing
Med ical Education . He is
survived by his wife, Lois , and
three so ns.
David W. Beggs '55 died
May 24. He was on th e
dermatology staff at River
View Medi cal Cen ter in Red
Bank. At th e 21st Annua l Art
Exhibit held in co njunc tio n
with the 1993 annua l meeting
of th e Ame rica n Acade my of
Dermatology, h is entry was
award ed first place in ph otog-
raphy and was declared "Best
of Show." He is su rvive d by
his wife, Evelyn, a so n, and
a daughter.
Mars'tall A . Pepper '59 died
September 29. He prac ticed
in ternal medi cine in Miami ,
and was a medi colegal expert
with a Miami law firm. He is
survived by his wife,jan ice, a
so n, and a dau ghter.
Josep'IJ. Prorou '63 died
September 2. A board-cert ified
general surgeon , he practiced
in Allentown, PA. He was an
attending surgeon at Sacred
Hea rt Hospital and a senior
atte ndi ng surgeon at Leh igh
Valley Hospital. He was
Clinical Instru ctor of Surgery
at the Medica l Co llege of
Pennsylvania from 1970 to
1974. He is su rvived by his
wife , Sylvianne, three so ns ,
and th ree dau ghters .
Robert L. HellmcUl '71 died
May 24 . He was a board-
certifie d pat hologis t and was
Asso ciat e Professor of
Pa tho logy at the University
of Miam i Schoo l of Med icine,
Miami , FL. He was Director
of UM's Pathology Reference
Servi ces and , from 1981 to
1988, he was Director of the
pathology resid en cy educa tio n
program at th e medical schoo l.
He is survived by his wife,
Susa n.
Hug 'l P. Sdlieren, P'I.D.,
Assista nt Professor of
Anes thesio logy and
Pha rma co logy, d ied Septe mber
9 . After an illusti ou s caree r in
acade mia and indust ry, he
joined the jefferson faculty in
1988 as Assistant Professor of
Anes thesio logy an d Director
of the Anest hesia Research
Laboratory. In thi s capac ity
he provided th e laboratoy
support for departmen tal
clin ical stud ies and se rved as
a me ntor for young faculty
members , resid ents , and
medical stude n ts. He is
survived by his wife, j an ,
and th ree daughters.
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Preferred Add ress _
Spouse's Name _
Daytime Phone _
a long illness. She had been
ac tive in civic affairs .
'55
Edwi JI D. Ars'lf of Springfield,
PA has ret ired from fami ly
pract ice after 35 years.
Robert G. Altsdmler has been
appo in ted an Inst ru cto r in
Medi cin e at j efferson.
RobertJ. Knrp has been
pr om oted to Professor of
Clin ical Ped ia trics at the Stat e
Universi ty of ew York at
Brooklyn. He recently
published an article in the
Archives of Pediatrics and
Adolescent Medicine and a
cha pter in Child llOod Nutrition
(C RC Press , 1995) .
Carl L. Stallits'li has been
awarde d the Citizen of the Year
Award by Operation Friendship
from th e Detroi t Public Sch ool
League . He set up an ou treach
pr ogram between the
Ort ho paedic Department at
Chi ldre n's Hospita l of Michigan
and th e Det ro it Publi c Schools
Edward W. LUCZYlIS'li has
ret ire d and he and his wife Sally
are living in Wi lliam stown, MA
and enjoying retire men t
immen sely.
Charles].
Sta'll III of
Rockville,
MD received
the Distin -
guished
Fellow
Award at
th e annua l meet ing of the
American Acade my of Forensic
Scie nces in Sea ttle. This award
was given in recognition of
"a lifet ime of service to the
forensic scie nces profession."
'56 40t h Reunion lune 7-9
'6 7
Zip _
'54
Erancis ] . Nash of Milton , MA
regrett abl y lost Mary , his wife
of man y years, a yea r ago after
'53
Burwell M. Kenlledy and his
wife, Dr. Mari an Kenned y,
received Ambassa dor's Awards
from th e Ameri can Ambassador
to th e United Arab Emira tes in
recognition of their con tribu-
tion s to medi cal services in th at
country . Th e Kennedys had
es tablished Oasis Hospital in
Al-Ain in 1960 and for IS yea rs
wer e closely ide n tified wit h th e
institution , which was kn own
informally as "Kennedy
Hospital. "
George T. W olff was awarded
the 1995 Distingui sh ed Service
Award by th e Universi ty of
No rt h Caro lina School of
Medi cine and its Med ical
Alu mni Association .
Robert Poole represented
jefferson at th e inaugurati on of
john Strass burge r as ll th
President of Ursinus Co llege ,
Coll egeville, PA.
State _
Class Year or Jeff Affiliation _
'42
MOll Q. Kwollg is volunteering
at the China town Service
Ce n ter Clinic in Los Ang eles.
His spec ialty is dermatology.
'45
Emil Howarlitz of Kingston , PA
is still pract icing and "would
not kn ow what to do if retired ."
He enjoys visiting his so n E.
Paul Howallitz '78 who is Chief
of Cardiothoracic Surgery at St.
joseph's Hospital in Reading.
5'44
'52
Robert L. Evalls was honored
with th e dedi cati on of th e
educationa l building at York
Hosp ital , York, PA in his nam e.
He se rved as th e first Dir ector
of Med ical Education at th e
hospital from 1960 to 1971.
] . W allace Davis was
nominated to honorary
membership in th e Alpha
Omega Alpha Honor Medical
Society by th e AOA members
from jefferson 's Clas s of '95.
Name _
City _
'38
William I. Hei lle of Elki ns
Park has writte n a book,
Edwin A. [arechi, M .D.,
Resident Physician , J ewish
Hospital of Philadelphia
1892-1934: A Centennial
Commcmoration, whic h was
published by Albe rt Eins tein
Medica l Center, Philade lphia,
where he is a se nior atte ndi ng
ph ysician , emeri tus.
Morris]. Shapiro was
inducted into th e Roch est er
j ewish Spo rts Hall o f Fam e at
the annua l dinner of th e
Roch est er , NY cha pter of
Spo rts for Israel at th e jewish
Co mmunity Center.
On behalf of th e Board of Directors of the jefferson Faculty Club, you are cordially invitedto join the club as a member of the Alumni Association. The dues from january I to .
june 30 , 1996 ar e $25 (including your spouse). The club is open for ~unch fron: 1l:30 u~t.ll
2:00 Monday through Friday, and is also available to members for private functions . To Jom,
simply fill ou t thi s form and enclose your check for $25 payable to the jefferson Fac~lty
Club; mail it to th e club at 1020 Locust Street M-32 , Philadelphia, PA 19107. You will
receive your membership card in the mai l.
~ .
Rarldolp' l V. Se ligma ll of
Albuque rque, after man y
years of pri vat e practice of
obste trics and gynecology, is
now teaching at the
Universi ty o f New Mexico
which he finds "very
enjoyable and rewardi ng. "
'40
Join the Faculty Club
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wh ere th ey provid ed preseason
ph ysical exami na tio ns for
th eir athletes and se minars
co nce rni ng injury recognition
and prevention for th eir
coaches . He was ve ry honored
to receive thi s awa rd which has
been given an nua lly since 1976.
'69
Judith Cooper Anderson has
been appointed interim Chief of
th e Department of Medicin e at
Det roit Medi cal Cen te r's Harper
Hosp ital. She is th e first woman
to lead th e department.
'70
Peter D. Pizzutillo has been
appo in ted Co-Chief of th e
Sec tio n of Ort ho paedic Surgery
at St. Ch ristophe r's Hospital
for Ch ild ren , Philadelphia,
and Professor of Ort ho paedic
Surgery and Pediatrics at
Medical College of Pennsylvania
and Hahnemann University.
'71 25th Reunion lune 7-9
Daniel B. Gould has
been helping to write th e
nephrology board exa m ove r
th e past three years "although
anes thes ia rem ains my full-
time delight. " Last seaso n he
was an extra- an ass istan t
sac ristan- in 10 performan ces
of Tosca by th e Opera The atre
of St. Louis. Son David is a
sopho mo re at jefferson.
'73
Marc R. Goldenberg ha s been
appointed an Instructor in
Surgery at j efferson.
'74
WilliamJ.
Gibbons
has been
ap poin ted
by th e
Trust ees of
th e Holy
Red eem er
Health Sys tem to serve on th e
Board of Director s for Holy
Red eem er Hospital and
Medi cal Ce nte r in
Meado wbroo k, PA. He has
also been elec ted President of
th e Medi cal Sta ff.
'75
Ellis R. Levin , Professor of
Medi cin e and Pha rmacology,
UC- Irv ine , and Chief,
Endocrino logy and
Metabolism, VA Medica l
Cen te r , Long Beach , has been
appo inted to th e edito rial
board of Tne iourna! oj
Biological Chemistry. He
recently publish ed a review
article on endo the lins in New
England jo urnal oj Medicine.
Bradley D. Wong of Honolulu
was selected for th e ann ua l
Excellence in Teac hi ng Awa rd
by th e stu de nts of th e j ohn A.
Burns School o f Medi cin e of
th e University of Hawaii.
'77
Thonms G. Shar'ley and his wife
Anne of Moo sic, PA are th rilled
a t th e addition of th eir littl est
son , jeffrey Patrick , now two
years old. Dr. Sharkey co nt inues
h is opht hal mol ogy practi ce.
'78
Robert P. Boran of Pottsville,
PA has been accepted as a
member of the Ame rican
Association of Hip and Knee
Surgeons . He and his wife Kitsy
ar e the proud parents of th eir
th ird daughter, Mary Margaret.
'80
Patrice Hyde has join ed
jefferson as a Clinic al Assistant
Professor of Dermatology and
Ped iatr ics.
Christine K. Stabl er of
Lancaste r was reelected to th e
Board of Directors of th e
Pennsylvania Academ y of
Family Physicians.
o
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Would you lihe to contact the Alumni Office electronically?
If so , yo u can send your name, class year/specialty,
e-mail address , and information such as address changes or
personal and professional changes to: fullaml@jeflin.tju .ed u.
Th e e-mail address of th e Bulletin is: iedl72W®tjuvm.tju.edu.
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Alumni Trustee of Thomas Jefferson University: On e is
elected each year for a three-year term (he or she may be
reelected for one additional term). Please submit names of
worthy candidates to "Attention: Alumni Trustee Committee,"
1020 Locust Street , Suite MAl , Philadelphia , PA 19 107.
Alumni Acllievement Award: Although th e award carries
no mon etary stipend, each recipient's name is permanently
affixed to a plaque prominently displayed at the entrance to
jefferson Alumni Hall. The recipient is presented with a
handsome silver tray, suitably engraved and bearing the seal
of th e medical college, as the highlight of the Alumni Banquet
injune. Th e Achievement Award Committee of the Alumni
Asso ciation is charged with the final selection; the committee's
decisions ar e not subject to review. Pleas e direct curricula
vitae and bibliographies of alumni whose professional
activiti es are sufficient ly outstanding to warrant consideration
to "Atte ntion: Achi evement Award Committee,"
1020 Locust Street , Su ite M-41 , Philadelphia, PA 19 107.
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Your diploma is from Jefferson Medical College
of Tho mas Jefferson University-please refer
to your degree in this way.
'81 15th Reunion june 7-9
Scott A. Brernnan has bee n
appointed an Instructo r in
Surgery at J efferson.
'83
)ohll G. Bertolillo writes th at
he "can now lay claim to th e
fact of living longer in his
present place th an in any othe r
since leaving th e Phi Ch i hou se
in 1983. However , as per th e
usual two to three yea r
rou tine ," he has a new job. In
July he ass ume d th e position of
Program Director of th e family
practice residen cy at Latro be
Area Hospital and has th e
lu xury of working with six
thi rd -year Jefferson stu de nts
on a daily basis . The
oppo rtunity is a fantasti c way
to kee p in touch with
undergraduat e medi cal
educa tion."
Peter A. Cogneui o f Waverl y,
PA is now President-Elect of
th e Pennsylvani a Acade my of
Family Physicians.
) osep" T. Maguire has been
appo in ted an Instructor in
Oph tha lmo logy at J efferson.
'84
Robert D. Wallace is head o f
th e Division of Plasti c and
Reconstructi ve Surgery at
Nava l Medi cal Center, San
Diego. He has been promot ed
to th e rank of Co mma nde r.
'86 10th Reunion june 7-9
David ) . Esche lman has been
appointed an Assistan t
Professor of Medi cin e at
J efferson, Debora', A .
Snyden llan has been appo in ted
an Instructor in Psychi at ry and
Human Behavior, and George
P. Va llw has been promot ed to
Clinica l Ass istan t Professor o f
Family Medi cin e.
'87
)uriz R. Bilyll has be en
appo inted an Instructor in
Oph thalmology a t Jefferson.
Harris S. Silver, an otolaryn-
go log ist, has joined MeritCare
Medi cal Gro u p in Fargo , NO.
'88
David A. Cautill i has joined
th e ort ho paedic surgery staff at
Hol y Rede em er Hospital and
Medi cal Center in
Meadowbrook, PA.
Patricia M. Curtin o f Chadds
Fo rd , PA and her husband
Tom are th e proud parents of
Ma ry Bridget Curtin White,
born Augus t 24 .
John). Sirotnak III completed
a residen cy in oto laryngo logy
at th e State Univers ity of New
York in Buffalo and is presently
co m pleting a fellow ship in
surgica l oncology of th e head
and neck at Rosw ell Park
Cancer Institu te in Buffalo . He
plans to join h is father ,Johnj.
Siro tnak jr. '59 , in privat e
practi ce in Scran ton, PA.
'89
Christopher T. Si egel and wife
Mar garet E. Groh of Chicago
proudly announce the arrival
of th eir so n, Evan Joseph
Siege l, on Augus t 17.
Denise G. Kreider VolosI,in
and husband Michael of
Hermitage , PA ar e the proud
parents of Andrew Michael ,
born December 24 ,1994.
'90
Sandra eI,em completed a
fellowship in vitreoretina l
disea se and surgery at th e
Massachusetts Eye and Ear
Infirmary in Boston.
Maury A .[ayson has joined
Suffolk Uro logy Assoc ia tes in
Bay Shore, NY.
'91 Fifth Reunion lune 7-9
[ames W. Freeman has
completed his residency in
fami ly practice and joined his
father, William A. Freeman
'64 , and grandfather A lbert W.
Freeman '36 in Sh ippe ns burg,
PA. He and hi s wife Sadie
CAHS '88 ar e the proud par ents
of Hailey, now two years old.
Eric R. Rittenhouse has com-
pleted his residency and is now
practicing at St. Luke's Hospital
in Bethl ehem. His specialty is
obs te trics and gynec ology .
Maria E. Sop'lOdes of
Baltimore married John A.
Martin on July 22. She has
joined an ob/gyn prac tice with
Samuel F. Rudolph ]». '58.
'92
Kevin C. Mange has been ap-
pointed Chief Medical Resid ent
and an Instructor in Medi cin e
at th e Deaconess HospitallHar -
vard Medical School in Boston.
'93
Daniel B. Casto and Rachael
Pendleton BSN'93 were married
in Tucson on july 15.
)osep" A. Iocono of Palmyra,
PA has won a National
Research Fe llowship Award
from th e NIH. It is a two-year
fellowship to study wound
healing in th e Department of
Surgery at Pennsylvania Sta te
Universi ty's Hershe y Medi cal
Center, under department
chairma n Thomas Krummel,
M.D. J oe and his wife Susan are
th e proud pa rents of Amanda
Daniell e, born Oc tob er 1.
'95
Robin M. Samer is in the Eau
Claire Family Practice Residency
program in Eau Claire , WI.
Postgraduate Alumni
Sud ,a O. As bell RO'7 I is Chair
o f th e Department of Radiation
Oncology a t Albert Einstein
Medi cal Cen ter in Ph iladelphia.
Howard S. Caplan HSO '73 has
been appo in ted a Clinical
Ass istan t Professor of Surgery at
J efferson .
Daniel L W olIl FP'84 has been
appo in ted an Instructor in
Family Medi cine at Jefferson.
Francis E. Bed ler IM '85 joined
Int ernal Medi cine Associates in
Frede rick, MD.
Kathleen R. No ll AN'86 has
been appointed an Instru ctor in
Anes thes io logy a t Jefferson.
David M. Kastenberg GE'92 has
been promot ed to Clinical
Assistant Professor of Medicine
at J efferson.
Tarun ]. SIra', AI'93 has opened
a pra ct ice of allergy, asthma,
and clinical immunology in East
Brunswi ck , Nj.
Frank ], DeMartino EM'94 has
been appointed an Inst ru ctor in
Surge ry (E me rge ncy Medi cine)
at j efferson .
Elizabeth A . Sengstakell FP'94
has been prom ot ed to Clinical
Ass istan t Professor of Family
Medi cin e a t J efferson .
Timothy M. Greco OTO '94 has
been appointed an Instru ctor in
Otolaryn gology-H ead and Neck
Surgery at J efferson.
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I O lympic J MC T-Shirt
S, 1'01 , L, XL
2 Jack et: bcigc/blk , lined
S, 1'01 , L. XL, XXL
3 Baseba ll Cap: Wool/Sued e
4 Tu rtle neck: whi le , beige
S, 1'01 , L, XL
5 Basic Crew: gray, green , navy, hurgund y
Available Hood ed : gray , green , navy , bu rgundy
Avai lable T-Shirt : gray , gree n , na\ ')', hurgundy
6 Alumni Swea tshirt
S, 1'01 , L, XL, XXL
7 JM C Heavyw eight Swea t
8 J MC T-Shirt
9 Jeff erson Bou le Bag
10 Go lf Shirt Beige
S, 1'01 , L, XL, XXL
11 Kniu ed v : eck Swea ter
S, 1'01 , L, XL, XXL
12 Alumni T-Sh irt : na\')' , gray, burgundy
S, 1'01 , L, XL, XXL
13 Cad uce us T-Sh irt : white, gray
S, 1'01 , L, XL, XXL
Kid.' Corner
l ane Piece: Winged Ox
121'01 ,1 81'01 ,241'01
2 O ne Piece: Cow Jumped O ver
yello w o r mint 61'01 , 12M, 181'01 , 241'01
3 One Piece: Sho rt , Co w Jumped Over
61'01 ,1 21'01 , 181'01 ,241'01
4 J ump Suit: Winged Ox
121'01 . 18 1'01 , 24 1'01
5 Han dp aint ed Bib °Rx 2 Hugs"
6 Hooded Swea tshirt JM C
61'01 ,121'01 , 181'01 , zr.-+T, 6 , 8. 10. 12. 14
7 J MC T-Sh irt : gray, whi te
61'01 , 121'01 . zr, -+T, 5
8 J MC Baseb all Cap: one size
den im , ora nge , wh ite
9 Scru b Set:
Bear Design 2T , 4T
Bubbl e Gum Pink n , -+T, 5/b, 7/8 , 10112
Navy n , -+T, 5/6, 718, 10/1 2
G ree n rr , 4T, 5/6, 718, 10112
$ 14.95
569 .95
$ 14.95
S2 1.95
$29 .95
$40 .95
$ 14.95
$29 .95
557 .95
$ 15.95
$6 .99
38 .95
59 .95
$ 15.95
$ 11.95
17.95
16.95
$ 12.95
S 16 .95
S5.95
524.95
S IO.95
8.9 5
14.95
Fax your order to JEFFERSON BOOKSTORE fax 215 9231844
or ma il to BOOKSTORE . 224 S. 11th Street. Philadelphia. PA 191D7 lphone 215 955 7922 )
Sh ip to : Name _
Address _
Ci ty SI:1Ie Zip _
No ca sh o r C.O.D. pl ea s e . O rde rs must be prepai d .
IT EM D ESC RIPTIO N COLO R SIZE OTY. PRI C E TOTAL
Sh ipp ing and Handl ing : If yo ur o rd e r tot a ls S I0 .00 o r less , add $3 .0 0 : $ 10. 0 I 10 $ 25 .00 , ad d $4 .00 : MER C HA ND ISE T O T AL
$ 25 .0 1 o r more, add $5 .00 . All items se nt via U.P.S . Please a llow 2-3 we ek s fo r d el ive ry .
PA residents add 7% sa les tax
Method of Payment: 0 Chec k (payab le to TJ U Bookstore) o Visa o MasterCa rd o American Express Discover ex ce p t o n clothi ng
Accou nt Nu m be r Ex pi ratio n Da te SH IPPING A D HA DLI G
Signa ture Da te o f O rd e r I I Day time Ph one
Return Pol icy : If yo u are not co m p le tely sa tisfie d wi th the m er ch andise yo u have purchased , s im ply return th e item TOTAL
wi th a co py o f th e packing slip an d indicat e th e reason for th e return. Your pa ym ent will be refunded within 30 days.
from the Jefferson Bookstore
2
Crystal Collec /ioll
JM C engraved
(personalized engraving availabl e)
I Wall Clock: 15x26
2 Revere Bowl
3 Rectangular Clock
4 Paperw eight
5 Win e Goblet
6 Ancora Vase
7 Sno wflake Tree Ornament
8 Desk Set (pen included )
Marble Book end s
Planer (not shown) 20x 12
TJU: Tradilion and lJerilClge by Wagner
TJU: Clm mo/agical lJis/ary by Wagner
and Savacoo l
Cross Clinic Poster (no t shown)
Auto Mug 140z
Jefferson Canvas Lunch Bag
Paper Cube: Winged Ox, Olle r Fountain
Pewter Glass Bott om Mug
Stein: 320z whit e/gold trim
JM C Water Boul e
JMC Citizen Watch : Men's
JM C Citizen Watch : Ladies'
Tie: Pediatric Doctor
Tie: Anatomi cal
a. DNA
b. Eyeball
c. Skele tal
d. Heart
Tie: Jefferson colors, BlIBlksilk
JM C Scarf: Faux Silk
JM C Padfolio
JM C Keychain
JM C License Plate: Brass
Silver
Jefferson Postcard s
Notecards: Winged Ox
Pewter Leu er Opener
Duke Tankard : Pewt er
Cross Collecnon
I Fountain Pen &: Ink: Medalist
2 Pen &: Key Chai n (Rollerball)
Medali st
Chrome
Class ic Black
3 Fountain Pen &: Ink: Titan ium
4 Rol lerball Pen s
a. Black
b. Sienna
c. Green Marbl e
d . Medali st
c. Titanium
5 JMC Chro me Set
Available in Black
6 JMC Ballpoint Pen :
a. Black
b. Navy
c. Burgundy
d . Grey
Availab le in chrome
7 Town send Ballp oint Pen
a. Sienna
b.Black
c. Gree n Marbl e
d. Medalist
c. Titanium
8 Town send Pen cil
3 . Sienna
b. Black
c. Medalist
d . Green Marble
c. Tit anium
$ 199 00
$74.95
$79 .00
$49.95
$24.00
$55 .95
$32.95
$77 .95
$83 .95
$79.90
$120.00
$72.00
$ 19.95
$4.99
$7.99
$5 .99
$30.00
$ 13.95
3.99
$ 119.95
$119.95
$ 10.95
$29.95
$22.00
$36 .95
$7.99
$4.99
$8.99
$7 .99
$.50
$4.99
$21.95
$49 .95
$85 .95
$39.95
$3 1.95
$42 .00
$85 .95
$79 .95
$33 .95
$50.95
$26.95
$ 17.95
$52.95
$5 1.95
As', fo r our ca/alog of tIIuhitlled ia sof tware alld ",ediea l s u!,!,lies

